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ABSTRACT 
 
 
Mechanical forces are known to play a key role in regulating various cellular 
functions that control human development, cancer, disease, and aging. It, however, 
remains elusive how mechanical cues regulate biochemical mechanisms in the 
nucleus that control cellular decision-making. These mechanisms include 
epigenetic modification, chromatin organization, and gene expression. It is, 
therefore, highly important to investigate force-induced regulation of these 
mechanisms to better understand human physiology and disease. 
In this research, we aim at answering two key questions: one, how mechanical 
forces regulate epigenetics in tumor repopulating cells (TRCs), and two, how these 
forces unfold chromatin and induce gene expression in single living cells.  
Our findings suggest that mechanical forces play critical roles in regulating nuclear 
structure and function. Biomechanical cues can propagate deep inside the nucleus 
and regulate epigenetics, chromatin organization, and gene expression. 
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CHAPTER 1. INTRODUCTION 
1.1. Motivation 
Mechanical forces have been known to play a key role in regulating cellular 
function.1-3 Previous studies have shown that cells can sense biomechanical cues 
and respond to their microenvironment. These cues can directly or indirectly initiate 
a cascade of biochemical events, a process known as mechanotransduction.1  
It, however, remains elusive how these mechanical forces are transferred to the 
nucleus where cellular decision-making process is regulated. Understanding the 
mechanisms by which nuclear events are mediated by force will eventually 
elucidate the pathways involved in human development, disease progression, 
cancer, and aging.  
1.2. Objectives and Outline of the Dissertation 
In this dissertation we investigate the biomechanical regulation of two key nuclear 
events, namely epigenetic modification and chromatin organization, both of which 
tightly regulate gene expression. 
In chapter 2, we study how mechanical forces can control tumorigenicity of cancer 
cells. Specifically, we study epigenetic modification as a possible mechanism that 
controls gene expression and plasticity in tumor repopulating cells (TRCs). We 
further study the contribution of matrix softness to histone H3K9 methylation and 
Sox2 expression. We investigate possible pathways that matrix softness and 
mechanical forces contribute to cancer progression and relapse. 
In chapter 3, we investigate the effect of mechanical forces on chromatin 
organization and gene expression. In this chapter, we study how mechanical forces 
stretch chromatin and induce gene expression. We investigate the stress 
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propagation pathway from cell surface to the chromatin and show how exogenous 
and endogenous forces can regulate chromatin organization. 
In chapter 4, we present the conclusion and future directions of this dissertation. 
1.3. References 
1. Wang, N., Tytell, J. D. & Ingber, D. E. Mechanotransduction at a distance: 
mechanically coupling the extracellular matrix with the nucleus. Nature Reviews 
Molecular Cell Biology 10, 75–82 (2009). 
2. Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs 
stem cell lineage specification. Cell 126, 677–89 (2006). 
3. Vogel, V. & Sheetz, M. Local force and geometry sensing regulate cell functions. 
Nature Reviews Molecular Cell Biology 7, 265–75 (2006). 
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CHAPTER 2. BIOMECHANICAL REGULATION OF 
EPIGENETICS1 
 
2.1. Introduction 
Tumor-initiating cells (TICs) are a self-renewing, highly tumorigenic 
subpopulation of cancer cells. They play a critical role in the initiation and 
progression of cancer1. These tumorigenic cells exhibit high chemo-resistance to 
conventional chemotherapeutic drug treatment and therefore are speculated to be 
key players in cancer relapses after chemotherapy2. However, the concept of TICs 
has been controversial. Past reports show that a high percentage (>25%) of human 
melanoma cells can generate a tumor in a NOD-SCID interleukin-2 receptor 
gamma chain null (IL2r-/-) mouse3,4 suggesting that there is no hierarchy of clonal 
repopulation in melanoma. We recently developed a mechanical method of 
selecting TICs from cancer cell lines and primary cancer cells by culturing single 
cancer cells in soft fibrin gels5. Remarkably, in addition to being able to generate 
local primary tumors in wild-type syngeneic mice, when injected in tail veins, as 
few as 10 of such cells can generate distant metastatic colonization and grow tumors 
in the lungs of wild-type non-syngeneic mice. Therefore, we functionally define 
these soft-fibrin-gel-selected melanoma cells as tumor-repopulating cells (TRCs) 
based on their high efficiency in repopulating tumors in wild-type syngeneic and 
non-syngeneic mice. Soon after our report, three other groups independently 
provide strong experimental evidence in mice that TRCs do exist in brain6, skin7, 
                                                 
1 This chapter has already been published as Tan Y, Tajik A, Chen J, Jia Q, Chowdhury F, Wang 
L, Chen J, Zhang S, Hong Y, Yi H, Wu DC, Zhang Y, Wei F, Poh YC, Seong J, Singh R, Lin LJ, 
Doğanay S, Li Y, Jia H, Ha T, Wang Y, Huang B & Wang N Matrix softness regulates plasticity 
of tumour repopulating cells via H3K9 demethylation and Sox2 expression, Nature 
Communications 5, 4619, doi: 10.1038/ncomms5619 (2010). 
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and intestinal8 tumors. In vivo imaging of unperturbed tumors further confirmed the 
existence of TRCs9,10. However, the underlying mechanisms of how TRCs maintain 
their self-renewing capability remain elusive. In the current study, we demonstrate 
that melanoma TRCs exhibit plasticity in mechanical stiffening, H3K9 
methylation, Sox2 expression, and self-renewal. 3D soft fibrin matrices promote 
H3K9 demethylation and increase  Sox2 expression and self-renewal whereas stiff 
ones exert opposite effects. 
2.2. Results 
Self-renewal plasticity of TRCs. It is known that soft substrates can sustain self-
renewal of mouse embryonic stem cells (ESCs)11 and substrate rigidity can regulate 
the fate of mesenchymal stem cells12, indicating that rigidity of extracellular matrix 
plays an important role in the maintenance and regulation of stem cell properties. 
Since TRCs are selected from a population of melanoma cells that are usually 
cultured on rigid plastic, we asked what would happen if we plated these TRCs 
back to rigid substrates. To determine the effect of substrate rigidity on the gene 
expression, we cultured TRCs on rigid plastic for 1, 3, 5, and 7 days, and quantified 
their Sox2 expression. TRCs gradually lost Sox2 expression in both mRNA and 
protein levels along with the culture time on plastic (Fig. 2.1a, b; Fig. 2.28c,d). Sox2 
expression of TRCs was dramatically decreased after 1 day and was as low as that 
of control cells after 3 days on plastic. Other stem cell genes Bmi-1, C-kit, Nestin, 
and Tert, which are upregulated in TRCs5, were also downregulated after culture 
on plastic (Fig. 2.11).  
To examine the functional consequences of the loss of Sox2 and other stem cell 
genes, we re-plated those TRCs back into 90-Pa soft fibrin gels after culture on 
rigid substrates for 1, 3, 5, and 7 days, respectively. The growth rate of spheroids 
in fibrin matrices was successively decreased with the culture time of TRCs on 
plastic (Fig. 2.1c), which is not a result of the increased apoptosis rate (Fig. 2.12). 
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Moreover, colony number was also decreased (Fig. 2.13). After 7-day culture on 
plastic, TRC colonies proliferated at a similar rate as control cells (harvested from 
rigid dishes). The lower colony size and number suggest that rigid substrates 
significantly reduce the self-renewal capability of TRCs, likely due to the loss of 
Sox2 and other stem cell gene expressions. 
Besides the differences in gene expression patterns, TRCs also differ from control 
melanoma cells in their non-stiffening response to the increase in substrate rigidity5. 
To explore whether switching to rigid plastic may also change biophysical 
properties of TRCs, we first seeded them on 2D rigid plastic for 1-7 days, and then 
quantified their stiffness on polyacrylamide (PA) gels of different rigidities. TRCs 
started to stiffen with substrate rigidity after 1-day culture on plastic (Fig. 2.1d). 
The stiffening response was more evident after 3 and 5 days. Interestingly, after 7-
day culture on plastic, the stiffness and the stiffening response of TRCs were 
essentially the same as those of control melanoma cells (Fig. 2.1d). 
H3K9 methylation of TRCs is regulated by soft matrix and differentiation. Our 
data have shown major differences in self-renewal gene expression and biophysical 
properties between TRCs and control melanoma cells. Since these two types of 
cells are genetically identical, we hypothesized that epigenetics may play a role in 
it. A large body of work has shown aberrant changes in epigenetic features during 
tumor initiation and progression13,14, including histone modification. Among those 
aberrations, H3K9 is hypermethylated in several types of tumors15, 16. We asked 
what role H3K9 methylation plays in TRCs. To explore H3K9 methylation of 
TRCs, we developed a CFP-YPet H3K9 fluorescence resonance energy transfer 
(FRET) biosensor (fused with a nuclear localization signal (NLS)) modified from 
a previously reported CFP-YFP H3K9 biosensor17 to quantify H3K9 di- and tri-
methylation (me2 and me3) in the nucleus of single individual cells (Fig. 2.14a). 
This FRET probe uniquely measures the spatial distribution of H3K9 methylation 
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level in the nucleus and revealed that H3K9 me2 and me3 mostly occurred at the 
nuclear periphery (Fig. 2.14b). Culturing control cells in 90-Pa fibrin gels for 
merely 3 hrs resulted in H3K9 demethylation (Fig. 2.2a). TRCs did not elevate their 
H3K9 methylation (within 15 hrs of plating) with substrate stiffness on PA gels 
coated with either collagen-1 or fibrinogen (Fig. 2.2b, d); in contrast, control cells 
increased their H3K9 methylation with substrate stiffness on PA gels coated with 
collagen-1 but not with fibrinogen (Fig. 2.2b, c). Interestingly, high level of H3K9 
methylation in control cells was associated with high cellular tractions on collagen-
1 coated substrates and inhibition of the tractions decreased H3K9 methylation 
(Fig. 2.15), suggesting that high endogenous forces transmitted via 1/21 
(collagen-1 receptor) rather than via v3 (fibrinogen receptor) might be 
responsible for the stiff substrate mediated H3K9 methylation, consistent with a 
report that activation of 1 integrin but not 3 integrin elevates cell traction forces18.  
To further explore the role of physical forces in H3K9 methylation, we applied 
exogenous forces via RGD-coated magnetic beads to single cells using magnetic 
twisting cytometry19 (Fig. 2.3a, b). On fibrinogen-coated stiff substrates (8 kPa), 
the applied forces induced significant increases in H3K9 methylation at the nuclear 
periphery within 60 min only in control cells, but not in TRCs (Fig. 2.3a-c). The 
force-induced H3K9 methylation was dependent on force magnitude and 
specifically mediated via 1 integrin, since low forces, forces applied via beads 
coated with poly-L-lysine, or forces applied after blocking 1 integrin with 
monoclonal antibody, was not able to induce H3K9 methylation (Fig. 2.3d). In 
addition, silencing H3K9 methyltransferase G9a or SUV39h1 (knockdown 
efficiency was ~50%; Fig. 2.4a) not only reduced the baseline level of H3K9 
methylation in control melanoma cells (Fig. 2.4c), but also completely blocked the 
force-induced H3K9 methylation (Fig. 2.3d), consistent with a report that these two 
enzymes are critical to H3K9 methylation20. In contrast, silencing or inhibiting 
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H3K9 demethylase KDM7 with siRNA or with Daminozide in cells in 3D soft 
fibrin gels increased H3K9 methylation levels (Fig. 2.4b). These data suggest that 
H3K9 methylation levels in these melanoma cells are controlled by both 
methyltransferases and demethylases. H3K9 methylation also depended on 
intactness of the cytoskeleton and cellular tension, since disrupting actin 
microfilaments with Latrunculin A or microtubules with colchicine and inhibiting 
MLCK with ML7 significantly lowered H3K9 methylation levels (Fig. 2.4d). 
While TRCs did not increase H3K9 methylation with substrate stiffness within 15 
hrs (Fig. 2.2b, d), they started to increase H3K9 methylation on collagen-1 coated 
plastic after 48 hrs (Fig. 2.3e). In contrast, TRCs treated with retinoic acid (RA) (a 
nonspecific soluble differentiation factor) for 60 min (similar in duration for 
external force-induced H3K9me; see Fig. 2.3c) increased H3K9 methylation levels 
(Fig. 2.3f), suggesting H3K9 methylation may be associated with the differentiation 
of TRCs.   
H3K9 demethylation-induced Sox2 expression is critical to TRC self-renewal. 
Since H3K9 methylation has been associated with inactivation of certain genes13-
15, we postulated that H3K9 demethylation might be related to Sox2 expression. 
Our western blotting analysis showed that control cells expressed higher levels of 
H3K9 me2 and H3K9 me3 compared to TRCs (Fig. 2.16a). Importantly, silencing 
H3K9 methyltransferase G9a or SUV39h1 in control cells significantly increased 
their Sox2 expression (Fig. 2.5a and Fig. 2.17a), suggesting that H3K9 
demethylation can increase Sox2 expression. To further investigate how H3K9 
demethylation promotes Sox2 expression, we performed chromatin 
immunoprecipitation (ChIP) assay to quantify H3K9 me2 and me3 levels in the 
promoter region of Sox2. H3K9 me2 and H3K9 me3 levels were ~50% higher in 
the promoter region of Sox2 in control cells than in TRCs (Fig. 2.5b; Fig. 2.16b). 
Silencing G9a or SUV39h1 in control cells greatly decreased their H3K9-me2 or 
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H3K9-me3 levels in the promoter region of Sox2 (Fig. 2.5b). Plating TRCs on 
plastic for 7 days elevated H3K9 me2 and me3 to the same levels as those in control 
cells (Fig. 2.5b; Fig. 2.16b). These results suggest that G9a and SUV39h1 
methylated H3K9 at the Sox2 promoter site blocks Sox2 expression. In contrast, 
TRCs did not express G9a and SUV39h1 proteins and silencing Sox2 in TRCs did 
not increase the expression of G9a or SUV39h1 (Fig. 2.18), suggesting that G9a 
and SUV39h1 may be independent of Sox2 expression.  
Since knocking down G9a or SUV39h1 can induce Sox2 expression in control cells, 
we further explored whether H3K9 demethylation can promote their self-renewal 
capability. Silencing G9a or SUV39h1 in control cells significantly increased the 
colony growth in soft fibrin gels to a level similar to that of TRCs (Fig. 2.5c and 
Fig. 2.17b), but the colony number was still two-fold less than that of TRCs (Fig. 
2.17c, d). However, simultaneously silencing G9a (or SUV39h1) and Sox2 
completely abrogated the colony growth but not the colony number (Fig. 2.19), 
suggesting that H3K9 demethylation promotes self-renewal capability of 
melanoma cells in a Sox2-dependent manner. H3K9 methylation is regulated by 
both methyltransferases and demethylases. Silencing KDM7, an important 
demethylase for H3K921, significantly elevated H3K9 methylation (Fig. 2.4b) and 
suppressed colony growth and number (Fig. 2.6a, b), likely through inhibition of 
Sox2 expression (Fig. 2.6c). Treatment with two separate inhibitors of KDM422 
(another demethylase for H3K9) led to dose-dependent inhibition of colony size 
and colony number (Fig. 2.20). Taken together, these data suggest that H3K9 
demethylation by deactivating methyltransferases and activating demethylases 
increases Sox2 expression and thus promotes self-renewal capability. 
 We further investigated the functional role of Sox2 in maintaining self-renewal of 
TRCs in vitro and in vivo. Silencing Sox2 greatly decreased the expressions of Sox2, 
Bmi-1, and C-kit in TRCs (Fig. 2.21). Colony growth was suppressed by more than 
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90% in Sox2-knocked down TRCs in comparison to that of control TRCs (Fig. 
2.5d), suggesting that Sox2 is essential in maintaining self-renewal of TRCs in vitro. 
Sox2 silencing had no effects on control melanoma cells (these cells express little 
Sox2) that were grown on plastic and were then embedded in 3D stiff fibrin gels, 
suggesting that there were little off-target effects of Sox2 silencing (Fig. 2.22). 
Overexpressing Sox2 in control melanoma cells increased the colony number but 
not colony growth (Fig. 2.23), indicating that this intervention increases the number 
of self-renewing cells but does not alter cell cycle duration of a self-renewing cell. 
Importantly, subcutaneously injecting 100 of TRCs treated with Sox2 shRNA into 
wild-type syngeneic C57BL/6 mice did not generate any tumors by day 19. In 
contrast, palpable tumors were observed for untreated TRCs by day 13 and for 
treated with scrambled control shRNA by day 15. By day 28, 2 out of 16 mice for 
TRCs treated with Sox2 shRNA had small tumors (Table 2.1), whereas for 
untreated TRCs, 9 out of 16 mice formed large tumors; for TRCs treated with 
scrambled shRNA, 3 out of 8 formed tumors. The formation of tumors in TRCs 
treated with Sox2 shRNA appearing at late stages probably reflects the fact that the 
knockdown of Sox2 by shRNA was transient such that Sox2 expression came back 
in these cells after shRNA effect was depleted. As expected from previous 
findings5, injecting 100 of control melanoma cells (harvested from rigid plastic) did 
not form any tumors (0/8; Table 2.1). These data demonstrate that Sox2 expression 
is necessary to sustain self-renewal capability of TRCs both in vitro and in vivo.    
Because of the importance of Sox2 and H3K9 demethylation in TRCs, we asked 
what roles Sox2 expression and H3K9 methylation might play in the selection and 
propagation of TRCs by soft fibrin gels. When control melanoma cells were 
transfected with Sox2 shRNA and cultured in 90-Pa fibrin gels, both growth and 
number of spheroids were inhibited (Fig. 2.24a, b). Moreover, treatment with 
Daminozide, a highly selective inhibitor of KDM7, significantly inhibited TRC 
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spheroid growth number (Fig. 2.24c, d). Therefore, these data suggest that H3K9 
demethylation dependent regulation of Sox2 expression is important in TRC 
selection and propagation.  
Mechanism of cell stiffening with substrate stiffness. To elucidate the 
mechanisms of the stiffening response plasticity, we examined the potential role of 
Cdc42 in cell stiffening because of its known role in inducing filopodia formation 
and cell spreading in B16-F1 melanoma cells23. TRCs expressed ~50% less Cdc42 
than control cells; plating TRCs on plastic for 5 and 7 days increased their Cdc42 
expression by ~30% and ~100% (Fig. 2.7a). Overexpression of Cdc42 in TRCs 
rescued the cell stiffening response with substrate rigidity (Fig. 2.7b), whereas 
silencing Cdc42 in control melanoma cells or in TRCs on plastic for 5 days 
completely abolished the stiffening response (Fig. 2.7c). Silencing Cdc42 in 
melanoma cells on rigid plastic downregulated H3K9 me2 but not H3K9 me3 (Fig. 
2.7d; Fig. 2.25a, b) and had no effects on Sox2 expression (Fig. 2.25c), suggesting 
that Cdc42, cell stiffening, and H3K9 methylation might be linked via tension-
dependent cytoskeletal mechanotransduction, contributing to the biological 
plasticity of TRCs.  
Inhibition of TRC self-renewal by 3D stiff fibrin matrix. When the cells were 
cultured from 2D rigid dish to 3D soft matrix, both matrix dimensionality and 
stiffness were altered. To further determine whether it is the 3D matrix stiffness or 
the effect of switching from 2D to 3D matrix that impacts on the self-renewal 
capability of TRCs, we cultured control B16-F1 cells in 3D soft (90-Pa) or 3D stiff 
(1050-Pa) fibrin gels for 5 days. These cells were then seeded into either soft or 
stiff fibrin gels. After re-seeding the cells grew better in soft fibrin gels no matter 
whether they were derived from soft or stiff fibrin gels; in contrast, once re-seeded 
in stiff fibrin gels, colony growth and number were inhibited (Fig. 2.8a, b), 
suggesting that switching from a 3D soft matrix to a 3D stiff matrix inhibits self-
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renewal and promotes quiescence of the TRCs. When culturing control melanoma 
cells in soft and stiff fibrin gels, a 10-fold increase in substrate stiffness leads to a 
~1.25-fold increase in H3K9 me2 and a 50% increase in H3K9 me3 on the protein 
level and a ~90% decrease in Sox2 expression (Fig. 2.9). Importantly, switching 
from a stiff matrix (1050-Pa) to a soft matrix (90-Pa) significantly decreased H3K9 
methylation and elevated Sox2 expression by ~5-fold (Fig. 2.8c, d). Taken together, 
these data suggest that 3D stiff fibrin matrix can inhibit TRC self-renewal via H3K9 
methylation mediated Sox2 suppression.  
2.3. Discussion 
Increasing evidence has demonstrated that TRCs truly exist as a highly tumorigenic 
subpopulation that is critical to tumor initiation and progression. TRCs also exhibit 
high resistance to conventional chemotherapeutic drug treatment, which has been 
speculated to drive cancer relapse after chemotherapy. Therefore, TRCs may be 
one of the pivotal targets to achieve complete tumor eradication24. In the present 
study, we investigated how TRCs maintain their self-renewal capability. Since 
TRCs appear to be less differentiated, we set out to determine their specific lineage. 
Our data show that TRCs exhibited Sox2highMitflow phenotype and control 
melanoma cells exhibited Sox2-Mitf+ phenotype (Fig. 2.26a, b), consistent with 
published results25–27 and suggesting that TRCs resemble melanoblasts that are 
Sox2lowMitflow and control melanoma cells resemble melanocytes that are Sox2-
Mitf+ in these two gene expression patterns27. However, expression of Mitf 
upstream regulators, Pax328 and Sox1027, and melanocyte specific genes, 
tyrosinase-related protein 1 (Tyrp1)28, dopachrome tautomerase (DCT)28, and 
glycoprotein nonmetastatic melanoma protein B (Gpnmb)29, was similar in TRCs 
as in control cells (Fig. 2.26c, d). These findings suggest that melanoma TRCs may 
be progenitor cells of control B16-F1 cells but more differentiated than 
melanoblasts.   Moreover, knocking down Sox2 in TRCs increased Mitf expression 
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(Fig. 2.27a), while silencing Mitf (knockdown efficiency ~80%; Fig. 2.27b) in 
control melanoma cells did not affect Sox2 expression (Fig. 2.27c), suggesting that 
self-renewal gene Sox2 is independent of Mitf. Importantly, when TRCs are plated 
on the rigid dish, expression of melanocyte-related gene Mitf gradually increased 
(Fig. 2.28), demonstrating Mitf plasticity of TRCs when substrate rigidity was 
elevated, opposite in direction as the plasticity of Sox2 expression (see Fig. 2.1a, 
b).  
Sox2 is known for its critical role in the maintenance of pluripotency25 and fate 
determination30 of stem cells. Sox2 also sustains self-renewal capability of TICs26. 
Inhibition or silencing of Sox2 leads to loss of tumorigenicity26,31. Sox2 dysfunction 
in cancer32,33  is known, but it is not clear what triggers Sox2 expression in cancer. 
Our current study reveals a critical role of the mechanics of 3D matrix in Sox2 
expression in a sub-population of tumor cells. Importantly, silencing Sox2 greatly 
inhibits spheroid growth in vitro and tumor generation in vivo. TICs are 
heterogeneous in terms of their transient, long-term, or delayed-contributing effects 
on tumor growth34. While we cannot exclude the possibility that TRCs isolated 
from soft fibrin matrices are also heterogeneous, our previous finding that as few 
as 10 of these TRCs are sufficient to generate local and distant tumors5 suggests 
that these TRCs are distinct from those TICs.  
Cancer cells exhibit aberrant epigenetic features, including global changes in DNA 
methylation and altered histone modification35. On the other hand, stem cells have 
an open chromatin structure and abnormal epigenetic regulation may be prone to 
malignant transformation36. Here we show that H3K9 demethylation by silencing 
G9a or SUV39h1 can greatly promote the self-renewal capability of control 
melanoma cells in a Sox2-dependent manner whereas silencing H3K9 
demethylases inhibits self-renewal. It should be noted that in contrast to the increase 
in TRC colony number and growth observed following culture in soft substrates, 
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silencing H3K9 methyltransferases has significant functional effects on colony 
growth but not colony number and the levels of Sox2 remain 30-40-fold lower than 
those found in TRCs. The exact mechanism is not clear at this time, but it may be 
partly due to the fact that only 50% of G9a/SUV39h1 is knocked down whereas 
there are no detectable levels of G9a/SUV39h1 in TRCs (Fig. 2.18) and/or other 
self-renewal promoting effects of silencing G9a/SUV39h1 are at work. In addition, 
it is not clear why silencing Sox2, overexpressing Sox2, or inhibiting KDM4, has 
different effects from silencing methyltransferases on colony number and size. 
These issues need to be investigated in the future by dissecting out specific 
signaling pathways. Nevertheless, our data suggest that H3K9 demethylation and 
methylation, modulated by force-induced chromatin remodeling mediated by the 
cytoskeleton, can regulate Sox2 expression and play important roles in self-renewal 
and differentiation of TRCs. Our results show that stiff matrix induced H3K9 
methylation occurs at the nuclear periphery just under the nuclear envelope. Since 
the applied stress (via the magnetic bead) on the cell surface via integrins also 
induces H3K9 methylation at the periphery of the nucleus, suggesting that stiff 
matrix induced H3K9 methylation may be (at least) in part due to the elevation of 
endogenous stresses in the cell. These findings are in line with a recent report that 
force-induced stiffening of isolated nuclei depends on an intact LINC (linker of 
nucleoskeleton and cytoskeleton) pathway37. Cdc42 silencing decreases H3K9me2 
by ~20%, similar to that after disruption of cytoskeletal filaments with drugs (Fig. 
2.4d), suggesting that the effect of silencing Cdc42 might be important in altering 
cell functions. However, silencing Cdc42 has no effect on H3K9me3 or Sox2, 
suggesting that some molecule(s) upstream of Cdc42 may be important in 
controlling H3K9me3 and Sox2. Furthermore, our current findings suggest that 
increasing matrix rigidity affect Cdc42-mediated cell stiffening, H3K9 
methylation, and Sox2 suppression, but whether these are independent or linked 
pathways in controlling TRC function remains unclear and requires additional 
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experiments in the future. Published reports suggest that G9a/SUV39h1 mediated 
H3K9 methylation contributes to cancer initiation and/or progression13,14,16,38,39, 
different from our findings that G9a or SUV39h1 knockdown leads to Sox2 
expression. This discrepancy may lie in the fact that in those previous studies 
differentiated cancer cells are assayed whereas in our present study TRCs are 
analyzed. While there are reports on Sox2 expression in several types of 
undifferentiated tumor cells26,31, there is, to the best of our knowledge, no report of 
H3K9 methylation or Sox2 expression in TRCs when mechanical 
microenvironment is perturbed. Therefore, our findings on low force-mediated 
H3K9 demethylation and thus Sox2 gene expression are novel. Furthermore, we 
find that H3K9 methylation can directly inhibit Sox2 expression. Nevertheless, the 
potential roles of other histone modifications, such as H3K4 and/or H3K27 
methylation, acetylation and phosphorylation and DNA methylation, remain to be 
elucidated. In addition, the mechanisms of in vivo Sox2 expression/suppression 
with the link to H3K9 demethylation/methylation and matrix compliance/cell 
stiffening need to be investigated in the future. 
We show that a uniform stiff fibrin gel functions as a physical barrier to prevent the 
formation and growth of TRC spheroids through elevated H3K9 methylation 
induced Sox2 suppression, supporting a recent postulate on breast cancer 
progression40. Melanoma cells in the same soft fibrin gels can form round colony 
only at z-heights far away from the rigid plastic bottom (Fig. 2.29); since these cells 
experience the same porosity but different elasticity, these data demonstrate that it 
is matrix stiffness but not porosity that dictates round colony generation and self-
renewal. Furthermore, addition of soluble fibrinogen ligands to the 90-Pa fibrin 
matrix (total ligand amount is equivalent to that of 1050-Pa fibrin gels) did not alter 
colony growth (Fig. 2.30), suggesting that the difference in colony growth between 
90-Pa and 1050-Pa fibrin gels may not be due to ligand density availability. It is 
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noteworthy that the H3K9 methylation results and the corresponding traction data 
(and their inhibition by MLCK inhibitor ML7) suggest that different integrin 
subsets (i.e., collagen-1 mediated 1 integrin binding vs fibrinogen mediated 3 
integrin binding) can trigger different responses in H3K9 methylation even for the 
same substrate stiffness.  
Our data suggest that TRCs may have different cell fates in matrices of various 
mechanical and biochemical microenvironments (Fig. 2.10). In a soft matrix, TRCs 
can proliferate well and grow into a local tumor. In the presence of soluble 
differentiation factors, TRCs cannot proliferate even in soft matrix. In contrast, a 
stiff matrix restricts TRC growth and makes them quiescent. However, upon matrix 
degradation and remodeling, the stiff matrix may become locally softened, 
reactivating TRCs to proliferate, while some areas of local stiffening may promote 
TRCs to differentiate. Locally switching from 3D stiff matrices to 3D soft matrices 
and vice versa may be able to regulate TRC self-renewal, as suggested by our 
current results from in vitro culture. This scenario may partially explain why tumor 
relapses several years after surgery and therapies. These data indicate that stiff 
matrix may be used as an effective strategy to suppress self-renewal of TRCs. 
Published reports have shown that tension-dependent matrix stiffening is critical in 
breast cancer progression41–43. At a first look, it appears that there is a discrepancy 
in our findings and the results of these reports. A close examination reveals that our 
findings and theirs may be referring to different cancer cells at different stages 
during cancer progression. It is known that tissue stiffening alone cannot drive 
mammary epithelial transformation without ErbB2 activation43. It is possible that 
integrin-mediated, tension-dependent matrix stiffening facilitates differentiation 
and invasion of those TRCs only in the presence of matrix degradation by various 
proteases42 that generate more porous matrices of heterogeneous rigidity. This 
explanation is supported by the experimental finding that matrix metalloproteinease 
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(MMP) 14-mediated local softening of the invasive front of mammary epithelial 
cells is necessary to overcome the stiff elastic resistance of the collagen matrix44. 
As tens of thousands of cancer cells differentiate on the stiff matrix, invade, and 
then intravasate, few undifferentiated or partially differentiated cancer cells such as 
TRCs may follow these differentiated cancer cells and disseminate into the blood 
vessel. It is possible that only these soft TRCs can survive the distant organs to 
form metastatic colonization, the major rate-limiting step in clinically detectable 
macroscopic metastasis45. This interpretation may explain why metastatic 
colonization is such a highly inefficient process, with only ~0.01% intravasated 
cancer cells being able to form metastatic colonization45. The model that soft TRCs, 
which are much softer than differentiated cancer cells, are the key players in 
metastatic colonization is supported by a recent report that the core of human breast 
tumor tissues is much softer than peripheral tumor tissues and that metastatic tumor 
tissues in mouse lungs are much softer than surrounding normal lung tissues46. This 
soft cancer cell model is also supported by numerous reports over the last two 
decades from several labs that cancer cells, especially those metastatic cancer cells, 
are much softer than normal cells or non-metastatic cancer cells47–52. The long 
period of latency of disseminated carcinoma cells observed clinically45 might be 
partially explained by the dormancy of the TRCs inside the uniformly stiff matrix, 
which restrains them from proliferating. This postulate needs to be tested in the 
future in animal models. 
2.4. Methods 
Cell culture. Murine melanoma cell line B16-F1 was purchased from American 
Type Culture Collection (ATCC). Briefly, cells were cultured on rigid dishes with 
DMEM cell culture medium supplemented with 10% fetal bovine serum 
(Invitrogen), 2 mM L-glutamine (Invitrogen), 1mM sodium pyruvate, and 0.1 mM 
penicillin/streptomycin at 37°C with 5% CO2. Cells were passaged every 3-4 days 
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using TrypLE (Invitrogen). Glass or plastic culture dishes were coated with 
collagen-1 (0.2 mg ml-1) or sometimes with gelatin (0.1%) (denatured collagen) 
unless otherwise specified.  
3D fibrin gel preparation. Salmon fibrinogen and thrombin were purchased from 
Reagent Proteins (CA, USA). 3D fibrin gels were prepared as described 
previously5. In brief, fibrinogen was diluted into 2 mg ml-1 with T7 buffer (pH 7.4, 
50 mM Tris, 150 mM NaCl). Cells were detached from 2D rigid dishes and cell 
density was adjusted to 104 cells/ml. Fibrinogen and cell solution mixture was made 
by mixing the same volume of fibrinogen solution and cell solution, resulting in 1 
mg ml-1 fibrinogen and 5000 cells ml-1 in the mixture (for 2, 4, 8 mg/ml (180, 420, 
or 1050 Pa, respectively) fibrin gels, the initial concentration was increased to 4, 8, 
or 16 mg ml-1). 250 μl cell/fibrinogen mixture was seeded into each well of 24-well 
plate and mixed well with pre-added 5 μl thrombin (100 U ml-1). The cell culture 
plate was then incubated in 37°C cell culture incubator for 10 min. Finally, 1 ml of 
DMEM medium containing 10% FBS and antibiotics was added.  
Reverse transcription-PCR and real time RT-PCR analysis. Total mRNA was 
isolated from the cells using the Trizol reagent according to the supplier’s 
instruction (Invitrogen). Reverse transcription was performed using the TransScript 
First-strand cDNA Synthesis SuperMix (TransGen), according to the 
manufacturer’s protocol. RT-PCR was performed using a PCR kit (QIAGEN), and 
real time RT-PCR was performed using GoTaq® qPCT Master Mix (Promega). 
The data were normalized against mouse GAPDH. The sequences of all the primers 
for RT-PCR and real time RT-PCR were listed in Table 2.2 and 2.3.  
Chromatin immunoprecipitation assay. We performed ChIP assay following the 
manufacturer’s instructions (ChIP Assay Kit, Millipore). Briefly, cells were 
subjected to crosslinking with 1% formaldehyde in medium for 10 minutes at 37°C, 
and then lysised in SDS buffer for 10 min on ice. Chromatin was sonicated to shear 
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DNA to an average length of 0.2–1.0 kb. Antibodies to di- and tri- methyl-histone 
H3 (Lys9) (Abcam) were used for immunoprecipitation. Normal mouse IgG (Santa 
Cruz) was used as negative control. The immunoprecipitation was heated to reverse 
the formaldehyde cross-linking and the DNA fragments in the precipitates were 
purified by phenol/chloroform extraction and EtOH precipitation. The 
immunoprecipitated DNA was quantified by real time PCR.  Primers were sets 
corresponding to Sox2 and GAPDH (negative control) promoter regions. The 
sequences of these promoter regions were listed in Table 2.4 and can be found in 
Transcriptional Regulatory Element Database (TRED, Cold Spring Habor 
Laboratory).  
Western blot assay. To quantify the expression levels of G9a, SUV39h1, H3K9 
di- and tri-methylation, cells were lysed with 200 l Laemmli sample buffer 
(beyotime).  Twenty µl of each sample were separated by 8%-15% SDS-PAGE, 
blocked with 5% BSA overnight at 4°C, and incubated with primary antibodies 
to G9a (Rabbit, 1:1000, Cell Signalling, #3306), SUV39h1(Rabbit, 1:1000, Cell 
Signalling, #8729), H3K9 di-methylation (Rabbit, 1:300, Millipore, # 17-648 ), and 
tri-methylation (Mouse, 1:300, Millipore, # 17-625) for 2h at room temperature. 
Primary antibodies were detected  with  goat anti-Rabbit IgG-HRP (1:2000, Santa 
Cruz, sc-2004) or anti-Mouse IgG-HRP(, 1:2000, Santa Cruz, sc-2005). The blots 
were developed using SuperSignal West Pico chemiluminescent substrate 
(Millipore). 
FRET probe gene construction and plasmids. The plasmid of histone H3K9 
methylation reporter (ID 22866) is purchased from Addgene (Cambridge, MA). In 
brief, it includes a central fragment consisting of the methyl-lysine binding domain 
of HP1 protein and a histone peptide, which was further fused in between an N-
terminal CFP and a C-terminal YFP17. This plasmid was digested with BamHI and 
SacI and fused to predigested pRsetB (Invitrogen) containing C-terminal YPet and 
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NLS (nuclear localization signal). The reporter containing NLS was further 
digested and inserted into pcDNA3 (Invitrogen) to create modified histone 
methylation reporter for mammalian cell expression. The insert was sequenced (W. 
M. Keck Center for Functional and Comparative Genomics, University of Illinois 
at Urbana-Champaign) to verify the integrity of the coding sequence. FRET 
reporter was transfected into the cells using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s protocols.  
Magnetic twisting Cytometry. Magnetic twisting cytometry (MTC) has been 
described elsewhere19, 53. Arg-Gly-Asp (RGD)-coated or Poly-L-Lysin (PLL)-
coated ferromagnetic beads (Fe3O4, 4μm in diameter) were added to cells and then 
incubated for 30 minutes to allow for integrin binding and clustering. Beads were 
then magnetized in horizontal direction by applying a strong magnetic pulse (1000 
Gauss for 100μs). A sinusoidal oscillatory waveform was applied at 0.3Hz for 1 hr 
to the apical surface of the cell. The amplitude of the magnetic field was varied at 
35, 50, and 70 Gauss corresponding to 11, 15.9, 22.2 Pa applied stress. The apparent 
applied stress is defined as the ratio of the applied torque to six times the bead 
volume and equals the bead constant times the applied twisting field. Cells were 
plated on collagen-coated (0.2 mg ml-1) or fibrinogen-coated (0.2 mg ml-1) 
polyacrylamide gels with different rigidities or glass/plastic. Stiffness was 
quantified 6 hrs later. Cells were maintained in CO2-independent medium 
supplemented with 10% serum (Invitrogen) at 37° C during experiments.  
A Leica inverted microscope integrated with the MTC device and Dual-View 
system (Optical Insight) was used to simultaneously apply stress and capture CFP 
and YFP (YPet) emission images. For emission ratio imaging, the Dual-View 
MicroImager (Optical Insights) was used. CFP/YFP Dual EX/EM (FRET) (OI-04-
SEX2) has the following filter sets: CFP: excitation, S430/25, emission S470/30; 
YFP: excitation, S500/20, emission S535/30. The emission filter set uses a 515-nm 
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dichroic mirror to split the two emission images. Cells were illuminated with a 100-
W Hg lamp. For FRET imaging, each CFP (1,344 pixels × 512 pixels) and each 
YFP image (1,344 pixels × 512 pixels) were simultaneously captured on the same 
screen by using a CCD camera (C4742–95-12ERG; Hamamatsu) and a 40X, 0.55 
N.A. air-immersion objective. A customized Matlab (Mathworks) program was 
used to analyze CFP and YFP images and to obtain YFP/CFP emission ratio. 
RNA interference. Cells were transfected with siRNA, or shRNA, or cDNA using 
Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol. Silencer® 
Negative Control No. 1 siRNA (Invitrogen, AM4611) was used a control in RNAi 
experiment. The construct sequence is GGUGAUCCUUAUGCUGUUAtt for G9a 
siRNA #1 (Invitrogen, #90322), GGUGACUUCAGAUGUGGCCtt for G9a 
siRNA #2 (Invitrogen, #90133), GGUCCUUUGUCUAUAUCAAtt for SUV39h1 
#1 (Invitrogen, #69566), GGUGUACAACGUAUUCAUAtt for SUV39h1 #2 
(Invitrogen, #151927), and AGUACUGCUUACGAUACGGtt for Negative 
Control siRNA. KDM7 siRNA #1 (Santa Cruz, sc-146320) is a pool of 3 different 
siRNA duplexes, sc-146320A, sc-146320B, and sc-146320C, the sequence of 
which is GUAGUAUACCGCAGCUUAAtt, GUGAAUGGUUAGCAAUACAtt, 
and GAGAAUGUCUCGCCUUUCAtt, respectively. The sequence of KDM7 
siRNA #2 is GAAAUAACAUCACACUUUAtt (Invitrogen, #503916). Mitf 
siRNA was purchased from Invitrogen (#155366) and the construct sequence is 
GGUAUGAACACGCACUCUCtt. Cdc42 siRNA was acquired from Invitrogen 
(Cat#: 66023) and the construct sequence is GGGCAAGAGGAUUAUGACAtt. 
Sox2 shRNAs were obtained from Origene (TG515613). The construct sequence is 
GCACTACCAGAGCTAACTCAGATAGTACT for scrambled shRNA, 
GTATAACATGATGGAGACGGAGCTGAAGC for shRNA #1, 
AGACGCTCATGAAGAAGGATAAGTACACG for shRNA #2, 
AGCTACGCGCACATGAACGGCTGGAGCAA for shRNA #3, and 
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AACATGATGGAGACGGAGCTGAAGCCGCC for shRNA #4. The Sox2 cDNA 
was obtained from Origene (MG204615). The Cdc42-EGFP plasmid (ID 12975) 
was purchased from Addgene. pEGFP-N1 vector (Clotech) was used as control. 
Traction measurement. We followed the protocols of cell-traction quantification 
published previously11. In brief, cells were plated on polyacrylamide gels with red 
fluorescent beads (0.2 µm in diameter; Molecular Probes®, Invitrogen) embedded 
on the top surface.. Before and after cell trypsinization, fluorescent images were 
taken to compute the displacement field of the beads using digital image correlation 
(DIC)in a homebuilt MATLAB program . Cell tractions were then calculated from 
the displacement field using inverse Boussinesq mathematical model. 
Mice experiments. Four-week old female C57BL/6 mice were purchased from 
Wuhan University Center for Animal Experiment. All animals had received 
humane care in compliance with the Principles of Laboratory Animal Care 
Formulated by the National Society of Medical Research and the guide for the 
National Institutes of Health of USA. The protocol was approved by the Animal 
Care and Use Committee of Wuhan University.  B16-F1 cell spheroids were 
selected from 3D 90-Pa fibrin gels and pipetted to single cells. These TRCs were 
then transfected with Sox2 shRNA or scrambled control via lipofectamin 2000 
(Invitrogen) following the manufacturer’s protocol. These cells were harvested and 
the cell number was counted under microscopy. The cells were then suspended in 
a 0.9% NaCl solution with appropriate cell density. 100 of TRCs transfected with 
Sox2 shRNA or scrambled control were subcutaneously inoculated or intravenously 
injected into the tail vein of wild type C57BL/6 mice. The tumor growth of injected 
mice was carefully monitored every day and tail-vein-injected mice were 
euthanized and observed for lung tumor formation after 50 days. 
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Colony number assay. By changing the focal planes along the z-axis (the direction 
of gel depth), the colony number was counted view by view. At least 3 wells of 
colonies were counted per condition per day.  
Statistical analysis. All statistics (except the Fisher’s exact test for analyses of 
mice experiments) were made by a two-tailed Student’s t-test. 
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2.6. Figures and Tables 
 
Figure 2.1. Inhibition of Sox2 expression and self-renewal of TRCs on 2D rigid substrates. (a) 
Sox2 expression at both mRNA level (top panel) and protein level (bottom panel). Control: B16-F1 
cells cultured on plastic. TRC: Control B16-F1 cells were cultured in 90-Pa fibrin gels for 5 days. 1 
day, 3 days, 5 days, or 7 days: TRCs were seeded on 2D rigid dishes for 1, 3, 5, or 7 days. Images 
are representatives of 3 independent RT-PCRs and 2 independent western blotting experiments. (b) 
Quantification of Sox2 expression by real time RT-PCR. Mean ± s.e.m.; n=3 independent 
experiments. *p<0.05. (c) 2D rigid substrates inhibit TRC growth. Significant differences between 
Control and TRC, or 1 or 3 days from Day 1-5 in the 90-Pa fibrin gels (all p<0.05, except TRC at 
day 2, where p=0.068, 1 day at day 2, where p=0.52, and 3 days at Day 2 and Day 3, where p>0.15). 
No differences between Control and 5 or 7 days from Day 1-5 (all p>0.06, except 5 days at Day 1 
and Day 3, where p<0.04). Each data point was averaged from at least 30 colonies. *p<0.05 between 
TRC and all other groups. (d) 2D rigid substrates promote stiffening of TRCs with substrate rigidity. 
B16-F1 cells cultured on plastic were used as a control. All were compared to “0.15 kPa” in each 
group. Mean ± s.e.m.; *p<0.01. Each data point was averaged from >150 cells from two independent 
experiments. All the statistics were conducted using Student's t-test throughout the manuscript 
unless otherwise specified.  
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Figure 2.2. Matrix rigidity mediated H3K9 methylation in control cells but not in TRCs. (a) 
H3K9 methylation is lower in 90-Pa fibrin gels than on rigid plastic. Control B16-F1 cells were 
transfected with the H3K9 FRET methylation biosensor and were then plated either on gelatin 
coated rigid plastic (2D plastic) or in the 90-Pa soft 3D fibrin gel (3D Fibrin). H3K9 methylation 
was measured at the indicated times after cell plating. Mean±s.e.m.; n>75 cells for each value 
(*p<0.001). (b) H3K9 methylation in control B16-F1 cells (Control) but not in TRCs increases with 
stiff PA substrates coated with collagen I (Col-1) but not fibrinogen (Fib). PA=polyacrylamide. 
H3K9 methylation was measured 15 hrs after cell plating. Mean±s.e.m., n>40 cells for each value 
(*, p<0.005).  (c) and (d) Representative FRET images of a cell nucleus for control cells (c) and 
TRCs (d) on PA gels coated with collagen I (top panel)) or fibrinogen (bottom panel). Scale bars = 
5 m. 
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Figure 2.3. Exogenous forces increase H3K9 methylation level via 1 integrin. Exogenous 
forces increase H3K9 methylation in control B16-F1 cells (a) but not in TRCs (b). Top: bright-
field and fluorescence overlay image of the cells; the magnetic bead is shown as a black dot. Bottom: 
representative FRET images showing the spatial distribution of H3K9 methylation in the nucleus 
during loading. Cells were plated on 8 kPa polyacrylamide gels coated with fibrinogen and loaded 
at 24.5 Pa, 0.3 Hz with RGD-coated ferromagnetic beads. H3K9 methylation clearly increases in 
(a) at the nuclear periphery 30-60 min after loading. Scale bars 10μm (top), 5μm (bottom). (c) 
Quantification of H3K9 methylation in (a) and (b) during loading. (d) No force-induced elevation 
of H3K9 methylation was observed when the externally applied stress magnitude was equal or less 
than 17.5 Pa, when β1 integrin was blocked by a monoclonal antibody, when the force was applied 
via a poly-l-lysine coated bead, or when siRNA was transfected to knockdown G9a and SUV39h1, 
which are methyltransferases responsible for di-methylation and tri-methylation of H3K9, 
respectively. Knockdown of G9a and SUV39h1 was confirmed by Western blots that these proteins 
reduced by ~50% when compared with control. (e) H3K9 methylation in TRCs increases after 2-
day culture on glass dishes. TRCs were cultured on collagen I coated glass-bottomed dishes and 
H3K9 methylation was measured at indicated times.  Mean±s.e.m., n>40 cells for each time point, 
*p<0.05. (f) Short time treatment with RA increases H3K9 methylation in TRCs. TRCs were 
cultured on collagen I coated 8-kPa polyacrylamide gels for 15 hrs. Cells were then treated with or 
without (Control) 10 µM RA. Note that all the values were normalized to the value at 0 min (15 hrs 
after plating). Mean±s.e.m., n>40 cells for each value, *p<0.05.  
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Figure 2.4. H3K9 methylation levels depend on methyltransferases and demethylases and the 
tensed cytoskeleton. (a) Representative images of Western blotting of G9a or SUV39h1 expression 
after siRNA knockdown. Control melanoma cells were transfected with two sets of G9a/SUV39h1 
siRNAs (#1 and #2), respectively, and western blot assays were performed to confirm the 
knockdown efficiencies to be 48% (#1 siRNA) and 45% (#2 siRNA) for G9a, and 58% (#1 siRNA) 
and 43% (#2 siRNA), respectively. Three independent experiments showed similar results. (b) 
Silencing or inhibiting demethylase KDM7 increases H3K9 methylation of control melanoma cells 
in soft fibrin gels. Control cells were transfected with H3K9 FRET biosensors and KDM7 siRNAs 
(#1 and #2), negative control siRNA, or Daminozie were transfected or added. The cells were seeded 
into 3D soft fibrin gels and H3K9 methylation levels were measured after 3, 19, or 48 hrs. 
Mean±s.e.m.; n>40 cells for each data point; *, p<0.05. (c) Knockdown of G9a or SUV39h1 
decreases the H3K9 methylation in control B16-F1 cells. (d) Inhibiting microtubule, myosin light 
chain kinase (MLCK), or actin polymerization decreases H3K9 methylation. Control B16-F1 cells 
were incubated with Colchicine (Colch, 10μM for 30 minutes) to inhibit microtubule 
polymerization, ML7 (25μM for 30 minutes) to inhibit myosin light chain kinase, or Latrunculin A 
(LatA, 1μM for 30 minutes) to disrupt actin filaments. Mean±s.e.m; n>40 cells for each data point; 
*, p<0.05; **, p<0.001.  
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Figure 2.5. H3K9 demethylation mediated Sox2 expression is essential for in vitro tumor 
growth. (a) Silencing G9a or SUV39h1 promotes Sox2 expression in control melanoma cells, 
quantified by real-time RT-PCR. Neg Ctr: negative control. *p<0.05. (b) H3K9 di- (me2) and tri-
methylation (me3) levels in the promoter region of Sox2 quantified by the ChIP assay. TRC+7 days: 
TRCs were cultured on plastic for 7 days; Neg Ctr, siRNA: control melanoma cells were treated 
with negative control siRNA, G9a (for H3K9 me2) or SUV39h1 (for H3K9 me3) siRNA, 
respectively. *p<0.05. (c) H3K9 demethylation in control melanoma cells promotes their self-
renewal capability. Control cells were transfected with G9a or SUV39h1 siRNA and then re-plated 
in soft fibrin gels. (d) Silencing Sox2 greatly inhibits growth of TRC spheroids. TRCs were 
transfected with Sox2 shRNAs or scrambled shRNA. These cells were then re-plated into 90-Pa 
fibrin gels. Each data point was averaged from at least 40 colonies. In (c), significant differences 
between Negative Control and G9a siRNA #1 or SUV39h1 siRNA #1 or TRC from day 2 to day 5 
(*, p<0.005, except G9a siRNA #1 at day 2, where p=0.09). In (d), significant differences between 
Negative control or Scrambled control and Sox2 shRNA #1 to #4 from day 2 to day 5. (*, p<0.05). 
Mean±s.e.m.; n= 3 independent experiments for all subfigures. 
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Figure 2.6. Silencing H3K9 demethylase KDM7 greatly inhibits colony size and number 
through suppression of Sox2 expression. Knocking down KDM7 using two different siRNAs 
significantly inhibits colony size (a) and number (b). Control melanoma cells were transfected with 
KDM7 siRNA #1 or #2 and then cultured in 90-Pa fibrin gels. Colony number was counted and 
colony size was monitored until day 5 (n=2). There is significant difference between Neg Ctr and 
KDM7 siRNA #1 in (a) from day 2 through day 5 (all p<0.00001) and in (b) from day 1 through 
day 5 (all p<0.01), and between Neg Ctr and KDM7 siRNA #2 in (a) at day 4 and day 5 (both 
p<0.005) and in (b) from day 3 through day 5 (all p<0.05). “*” and “#” indicates significant 
differences between Neg Ctr and KDM7 siRNA #1 or #2, respectively. (c) Silencing KDM7 
significantly suppresses Sox2 expression. Control melanoma cells were transfected with KDM7 
siRNA #1 or #2 or negative control siRNA and then cultured in 90-Pa fibrin gels. After 5 days, Sox2 
expression was quantified by real time RT-PCR. *p<0.05; n=3 independent experiments.  
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Figure 2.7. Cdc42 expression regulates stiffening response and H3K9 me2 in melanoma cells. 
(a) TRCs express lower level of Cdc42 compared to control melanoma cells and TRCs after culture 
on rigid plastic for 5 or 7 days. n=6; *, p<0.05; two independent experiments. (b) TRCs regain cell 
stiffening responses after overexpression of Cdc42. Cells were plated on Collagen-I coated PA gels 
with different stiffnesses or on glass-bottomed dishes. Experiments were carried out 6 hours after 
plating. Relative changes in cell stiffness were represented with respect to the cell stiffness on 0.15 
kPa PA gel as the baseline. TRC + empty vector: TRCs were transfected with pEGFP-N1 vector; 
TRC + Cdc42 overexpression: TRCs were transfected with Cdc42-EGFP plasmid. n>150 cells; *, 
p<0.001. (c) Cdc42 knockdown inhibits cell stiffening in control cells and TRCs plated on plastic 
for 5 days. Relative changes in cell stiffness were represented with respect to the cell stiffness on 
0.15 kPa PA gel as the baseline. n>100 cells; *, p<0.001. Control: B16-F1 cultured on rigid plastic; 
TRC on plastic: TRCs were cultured on plastic for 5 days; Control + Cdc42 siRNA: control 
melanoma cells were transfected with Cdc42 siRNA; Control + Scrambled siRNA: control cells 
were transfected with scrambled siRNA; TRC on plastic + Cdc42 siRNA: TRCs were cultured on 
plastic for 5 days and then transfected with Cdc42 siRNA; TRC on plastic + Scrambled siRNA: 
TRCs were cultured on plastic for 5 days and then transfected with scrambled siRNA. Mean±s.e.m.; 
“*” indicates significant difference compared to “0.15 kPa”. (d) Quantification analysis of western 
blotting of H3K9me2 and me3 after Cdc42 knockdown in control melanoma cells. Mean±s.e.m.; 
n=3 independent experiments; *p<0.05.   
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Figure 2.8. Stiff matrix inhibits self-renewal of TRCs. Stiff fibrin gels inhibit colony growth (a) 
and number (b). “90-Pa to 90-Pa” and “90-Pa to 1050-Pa”: control B16-F1 cells were cultured in 
90-Pa fibrin gels for 5 days and these cells were then re-plated into 90-Pa and 1050-Pa fibrin gels, 
respectively. “1050-Pa to 90-Pa” and “1050-Pa to 1050-Pa”: control B16-F1 cells were cultured in 
1050-Pa fibrin gels for 5 days and these cells were then re-plated into 90-Pa or 1050-Pa fibrin gels. 
Spheroid size and number were measured from Day 1 through Day 5. In (a) and (b), significant 
differences between “90-Pa to 90-Pa” and “90-Pa to 1050-Pa” from Day 1 through Day 5 (all 
p<0.01); significant differences between “1050-to 90-Pa” and “1050-Pa to 1050-Pa” at day 4 and 
day 5 in (a) (both p<0.02) and from day 1 to day 4 in (b) (all p<0.05). Mean ± s.e.m.; n=2 
independent experiments. Each data point was averaged from >30 colonies. “*” and “#” indicates 
significant differences between “90-Pa to 90-Pa” and “90-Pa to 1050-Pa” and between “1050-to 90-
Pa” and “1050-Pa to 1050-Pa”, respectively. (c) Switching to 3D soft matrix decreases H3K9 
methylation. Mean±s.e.m.; n>50 cells from 2 independent experiments; *, p<0.05. (d) Switching to 
3D soft matrix increases Sox2 expression. Mean±s.e.m.; n=3 independent experiments; *, p<0.05. 
In (c) and (d), control cells were cultured in 1050-Pa fibrin gels for 5 days and then re-plated into 
90-Pa or 1050-Pa gels. After 24 or 48 hrs in (c) and 5 days in (d), their H3K9 methylation was 
measured by FRET and Sox2 expression was quantified by real time RT-PCR. 
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Figure 2.9. Stiff fibrin matrix elevates H3K9 methylation levels and suppresses Sox2 
expression. (a, b) Stiff fibrin matrix increases H3K9 methylation. Control cells were cultured in 90-
Pa or 1050-Pa fibrin gels 5 days. Their H3K9 methylation level was analyzed by western blotting 
assay (a) and quantified in (b). (c), Stiff fibrin matrix suppresses Sox2 expression. Control B16-F1 
cells were cultured in fibrin gels with the indicated stiffness for 5 days and then analyzed for Sox2 
expression by real time PCR. . Mean ± s.e.m.; n=3 independent experiments. *p<0.05; **p<0.01.  
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Figure 2.10. A working model of melanoma tumor growth and metastasis. TRCs proliferate in 
a soft matrix and eventually grow into a local tumor, while a stiff matrix restricts their proliferation 
and makes TRCs dormant. TRCs in the soft matrix can invade and self-renew and/or differentiate 
when the matrix is degraded and remodeled. When a soluble differentiation factor like retinoic acid 
is present, TRCs lose their proliferative property and stay quiescent even in soft matrix. However, 
upon matrix degradation, the dormant TRCs in the original stiff matrix start to self-renew in 
weakened and soft sites and to differentiate in remodeled and stiffened sites, leading to invasion and 
eventual metastatic colonization by TRCs in very soft tissues/organs with rigidity of ~100 Pa, 
similar to those undifferentiated TRCs. It is known that majority of metastases from many types of 
solid tumors is found in very soft organs/tissues like lung, brain, liver, and bone marrow45, but the 
underlying mechanism of this metastatic tropism is not understood. Since bone marrow stiffness is 
~100 Pa 54, brain stiffness is ~200-1000 Pa 54, liver stiffness is ~400 Pa 55, and lung stiffness is 100-
1000 Pa 56, all being very soft tissues, it is tempting to speculate that our model could be extended 
to metastases by other types of solid tumors, with implications in providing possible partial 
explanation to the conundrum of metastatic tropism. Clearly this working model needs to be tested 
rigorously in the future. 
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Figure 2.11. Expressions of stem cell markers decreased in TRCs on 2D plastic. TRCs were 
cultured on plastic for 1, 3, 5, or 7 days, respectively, and their mRNAs were quantified by real time 
RT-PCR for expressions of Bmi-1 (a), C-kit (b), Nestin (c), and Tert (d). Mean±s.e.m., n=3 
independent experiments. * p<0.05. 
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Figure 2.12. Low levels of apoptosis for cells in various conditions. The cells in Figure 2.1c were 
cultured in 90-Pa soft fibrin gels and live stained with 10 µg ml-1 propidium iodide (PI). The 
fluorescence images were taken from day 1 through day 5 for apoptosis analysis. The data represent 
the normalized fluorescence intensity (mean gray values divided by 255). The filled black circle or 
the filled triangle denotes a positive control, in which 2 µM doxorubicin was used to induce 
apoptosis 12 hr before day 5 or 100%  methanol was used to fix the cells at day 5 when control B16-
F1 cells were cultured in 90-Pa fibrin gels. Each value was averaged from > 20 colonies. The gray 
value of “0” means no fluorescence (0% apoptosis), while “1” means the highest fluorescence 
(100% apoptosis). “*” and “#” indicates significant differences (p<0.0001) between Control cells + 
Methanol or Control cells + Doxorubicin and all the others at day 5, respectively.  
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Figure 2.13. Reduction of colony number in TRCs after culture on rigid plastic. TRC: B16-F1 
cells were cultured in 90-Pa fibrin gels for 5 days. These TRCs were then re-plated on rigid plastic 
for 1, 3, 5, and 7 days, respectively, and re-seeded into 90-Pa fibrin gels. B16-F1 cells cultured on 
plastic were used as a control. There are significant differences between Control and all other 
conditions (all p<0.02) and between TRC and 1, or 3, or 5, or 7 days (all p<0.05, except 5 days at 
day 1, where p=0.055). Mean ± s.e.m.; n=2 independent experiments. “*” and “#” indicates 
significant differences (p<0.05) between Control cells or TRC and all the others, respectively. 
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Figure 2.14. Schematic of the H3K9 FRET probe. (a) H3K9 FRET probe and its specific function. 
See Methods section for details. (b) Expression of H3K9 FRET probe fluorescence within nucleus 
(left) and the quantification of YPet/CFP ratio in the nucleus was always performed in the area 
within the dashed blue lines (~1.5 μm from the nuclear periphery) (right). Scale Bars=5 μm. 
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Figure 2.15. Traction force of control B16-F1 cells increases with substrate stiffness, depends 
on the specific type of ECM protein, and is associated with H3K9 methylation. (a) 
Representative images of traction map of B16-F1 cells on polyacrylamide gels with various 
stiffnesses coated with fibrinogen or collagen 1. Scale bar=20 μm for all columns. (b) Traction 
forces increase with substrate stiffness and are much larger on collagen coated substrates. 
Mean±s.e.m.; n=10 cells per condition. (c) Inhibition of traction forces decreases H3K9 
methylation. Control B16-F1 cells were transfected with H3K9 FRET probe and plated on collagen-
coated 8 kPa gels. Tractions and H3K9 methylation level were measure before (0 min) and 20 
minutes after the addition of 2 M ML7). Mean±s.e.m.; n=6 cells per 
condition. *p <0.05.  
 43 
Figure 2.16. H3K9 methylation in TRCs and control melanoma cells. (a) Western blotting 
analysis of H3K9 di- (me2) or tri-methylation (me3) in various conditions. 7 days: TRCs were 
cultured on rigid plastic for 7 days; Neg Ctr: control melanoma cells transfected with negative 
control siRNA; siRNA: control melanoma cells transfected with G9a (for H3K9 me2) or SUV39h1 
(for H3K9 me3) siRNA #1. (b) ChIP assays for H3K9 me2 (left panel) and me3 (right panel) in the 
promoter region of Sox2. The immunoprecipitated DNAs at the indicated conditions were used for 
RT-PCR. Mouse IgG was used as negative control. To exclude non-specific effect, the relative 
expression in the GAPDH promoter was also shown.  
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Figure 2.17. Knockdown of G9a or SUV39h1 in control melanoma cells using another set of 
siRNAs also promotes Sox2 expression and self-renewal capability. (a) Knockdown of G9a or 
SUV39h1 in control melanoma cells using another set of siRNAs significantly increases their Sox2 
expression. *p<0.05. (b) Knockdown of G9a or SUV39h1 greatly increases the growth of tumor 
spheroids; (c) Knockdown of G9a or SUV39h1 increases the number of tumor spheroids. (d) 
Knockdown of G9a or SUV39h1 does not increase the colony number. In (b), there are significant 
differences between Negative Control and G9a siRNA #2 at day 5 (p=0.0015), or SUV39h1 siRNA 
#2 from day 2 to day 5 (all p<0.001), and between TRC and Negative control at day 4 and 5 (both 
p<0.03), or SUV39h1 siRNA #2 from day 3 to day 5 (all p<0.02), where “*” and “#” indicates 
differences comparing silenced cells with Negative control and TRC, respectively. In (c), there are  
significant differences between TRC and all the others from day 1 through day 5 (all p<0.001) and 
differences between Negative control and G9a siRNA #2 at day 4 and day 5 (both p<0.02), or 
SUV39h1 siRNA #2 at day 5 (p=0.03). “#” indicates significant differences between TRC and all 
the others.  Mean±s.e.m.; n=3 independent experiments for all subfigures. In (d), there are 
differences between Negative Control and G9a siRNA #1 or SUV39h1 siRNA #1 from day 1 
through day 5 (all p<0.05, except G9a siRNA #1 at day 2 and SUV39h1 siRNA #1 at day 1, where 
both p>0.05). “*” indicates significant difference between Negative Control and G9a siRNA #1 or 
SUV39h1 siRNA #1 and “#” indicates significant differences between TRC and all others.   
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Figure 2.18. Silencing Sox2 in TRCs does not affect expression of G9a and SUV39h1. TRCs 
were transfected with Sox2 shRNA for 13 hrs and the total proteins of these cells were extracted for 
western blot analysis on G9a and SUV39h1. No significant differences were found after Sox2 
silencing. Control cells: control B16-F1 cells cultured on plastic. Mean±s.e.m.; n = 3 independent 
experiments. Note that TRCs express no G9a or SUV39h1 protein. 
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Figure 2.19. Inhibiting Sox2 expression abrogates the increase in self-renewal capacity 
induced by H3K9 demethylation in control melanoma cells. Control melanoma cells were 
transfected with G9a or SUV39h1 siRNA and Sox2 shRNA concurrently and then seeded in soft 
fibrin gels. Their colony size (a) and number (b) were monitored from day 1 through day 5. Neg 
Ctr: negative control siRNA. Mean±s.e.m.; two independent experiments. In (a), there are 
significant differences between Neg Ctr and all the others from day 2 to day 5 (all p<0.02); in (b), 
there are only differences between Neg Ctr and Neg Ctr+Sox2 shRNA#3 at day 2 (p=0.026), or G9a 
siRNA#1+Sox2 shRNA#3 at day 2 and 3 (both p<0.05). “*” indicates significant differences 
between Neg Ctr and all the others.  
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Figure 2.20. Inhibiting H3K9 demethylase KDM4 dramatically prevents colony formation and 
growth. H3K9 demethylase KDM4 inhibitors JIB-04 (a, b) and DMOG (c, d) greatly suppress the 
colony size and number. Control melanoma cells were cultured in 90-Pa fibrin gels in the presence 
or absence of different doses of inhibitors. n=2 independent experiments. In (a) and (b), there are 
significant differences between Control and 0.2 µM or 1 µM JIB-04 from day 2 through day 5 (all 
p<0.000001 in (a); all p<0.02 in (b)). In (c) and (d), there are differences between Control and 0.8 
mM or 4 mM DMOG from day 2 through day 5 (all p<0.00001 in (c); all p<0.05 in (d). “*” indicates 
significant differences between Control and all the others.  
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Figure 2.21. Knockdown of Sox2 in TRCs greatly decreases the expressions of Sox2, Bmi-1, 
and C-kit. TRCs were transfected with Sox2 shRNA and their mRNAs were used to quantify the 
expressions of Bmi-1 and C-kit by real time RT-PCR. Mean ± s.e.m.; n=3 independent experiments; 
*p<0.05. 
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Figure 2.22. Silencing Sox2 expression has no effect on the colony number and size in stiff 
(1050-Pa) fibrin gels. Control melanoma cells were transfected with Sox2 shRNA or scrambled 
control and then cultured in 1050-Pa fibrin gels. Mean ± s.e.m.; n>80 colonies from 2 independent 
experiments; all p>0.05 except at day 2 in (a), where p<0.000001 as indicated by “*”. 
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Figure 2.23. Sox2 overexpression rescues the self-renewal capability of control melanoma cells. 
Control cells were transfected with Sox2 cDNA and then cultured in soft fibrin gels. The colony 
size (a) and number (b) were measured from day 1 through day 5. There are no differences in (a) in 
colony size and significant differences between Control and Sox2 cDNA from day 1 through day 5 
in (b). Mean+/-s.e.m; *p<0.01 between Control and Sox2 cDNA.  
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Figure 2.24. Sox2 expression and H3K9 demethylation are critical in the selection and 
propagation of TRCs by soft fibrin gels. (a) Inhibition of Sox2 up-regulation almost completely 
suppresses spheroid growth. Control melanoma cells were transfected with Sox2 shRNA and then 
cultured in soft fibrin gels. (b) Inhibition of Sox2 up-regulation significantly decreases spheroid 
formation. (c) Daminozide, inhibitor of H3K9 demethylase KDM7, significantly prevents colony 
growth but not spheroid formation (d). There are significant differences between Scrambled control 
and Sox2 shRNA #3 in (a) (all p<0.00001) and in (b) (all p<0.05) from day 1 through day 5. In (c), 
there are differences between Control and 2 µM or 20 µM Daminozide at day 4 and day 5 (all 
p<0.05). In (d), there are no differences between Control and 2 µM or 20 µM Daminozide. “*” 
indicates significant differences between Control and Sox2 shRNA #3 in (a) and (b) or between 
Control and 2 µM or 20 µM Daminozide in (c). Statistics analysis was also conducted between Sox2 
shRNA #3 in (a) or (b) and 2 µM or 20 µM Daminozide in (c) or (d), where all the data were first 
normalized by the respective Control. There are significant differences between Sox2 shRNA #3 
and 2 µM or 20 µM Daminozide from day 1 through day 5 in colony size in (a, c) (all p<0.000005) 
and in colony number in (b, d) (all p<0.04). 
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Figure 2.25. Silencing Cdc42 decreases H3K9 methylation but not Sox2 expression. (a) 
Representative western blotting images of H3K9me2 and me3 after Cdc42 knockdown in control 
melanoma cells. (b) Efficiency of Cdc42 knockdown. Mean±s.e.m.; n=3 independent experiments; 
*p<0.05. (c) Silencing Cdc42 has no effect on Sox2 expression. Mean±s.e.m., n=7 independent 
experiments.    
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Figure 2.26. Melanoma TRCs are the progenitors of control melanoma cells but more 
differentiated than melanoblasts. (a, b) Upregulation of self-renewal marker Sox2 and 
downregulation of melanocyte-specific gene Mitf in melanoma TRCs. (c, d) TRCs and control B16-
F1 cells express similar levels of melanin-related genes. After 5-day culture in 90-Pa fibrin gels, 
total mRNA of B16-F1 spheroid cells (TRCs) were extracted for detection of Sox2, Mitf (a, b), 
Pax3, DCT, Gpnmb, Tyrp1, and Sox10 (c, d) expression by RT-PCR (a, c) and real time RT-PCR 
(b, d). B16-F1 cells cultured on 2D rigid dish were used as a control. A representative of 3 
independent experiments in (a, c). Mean±s.e.m.; n=3 independent experiments; *p<0.05. 
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Figure 2.27.  Regulation of Mitf by Sox2. (a) Sox2 silencing in TRCs increases expression of Mitf. 
(b) Efficiency of Mitf knockdown. (c) Silencing Mitf in control melanoma cells (Neg Ctr) does not 
affect Sox2 expression. TRCs (or control cells) were transfected with Sox2 shRNA (or Mitf siRNA) 
and total mRNAs were extracted to quantify the expression of Mitf or Sox2 by real time RT-PCR. 
Mean±s.e.m., n=3 independent experiments. *, p<0.05. 
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Figure 2.28. Expression of melanocyte-related gene Mitf increased in TRCs after culture on 
rigid plastic. (a) Representative image of expression of melanocyte-related genes Mitf. Control: 
B16-F1 cultured on rigid plastic. TRC: Control B16-F1 cells were cultured in 90-Pa fibrin gels for 
5 days. 1 day, 3 days, 5 days, or 7 days: TRCs were seeded on 2D rigid dishes for 1, 3, 5, or 7days. 
(b) Quantification of Mitf expression by real time RT-PCR. Mean±s.e.m., n=3 independent 
experiments.*p<0.05. (c) Images with side markers show the gene sizes of GAPDH and Sox2 on 
the original gel in Fig. 1a. (d) Original Western blot images show the molecular weights of GAPDH 
and Sox2 in Fig.1a. 
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Figure 2.29. Matrix stiffness but not porosity affects round colony formation. Control 
melanoma cells were cultured in soft fibrin gels for 5 days. In the same gel, those cells near the rigid 
bottom formed spread colonies (a, b), while the cells far away from the rigid bottom formed round 
colonies (c, d). z: distances from the rigid bottom. Note that in (b) a round shadow is the round 
colony in (c) that is ~170 μm above (b).  
  
 57 
Figure 2.30. Additional soluble fibrinogen does not affect colony number and growth in soft 
fibrin gels. Control B16-F1 cells were cultured in soft fibrin gels (1 mg ml-1; 90-Pa) in the absence 
and presence of additional soluble fibrinogen (7 mg ml-1 soluble fibrinogen; total fibrinogen amount 
is equivalent to that of the 1050-Pa (8 mg ml-1) fibrin gel). Mean±s.e.m., n=3 independent 
experiments.  
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Table 2.1. Sox2 is necessary for high efficiency of tumorigenicity in vivo. 
Sox2 expression in TRCs was silenced following the same protocol as in Figure 2.4d. These cells 
were then trypsinized and the cell number was counted. 100 of untreated TRCs, TRCs treated with 
Sox2 shRNA, or scrambled control, or control melanoma cells (harvested from rigid plastic) were 
injected subcutaneously or intravenously via tail veins into wild-type syngeneic C57BL/6 mice, 
respectively. Tumor number and size measured at day 28 for subcutaneous injection (s.c.) are 
shown. The data are summarized from two independent experiments (each group 8 mice were used). 
 
 
Untreated 
TRCs 
TRCs + 
scrambled 
shRNA 
TRCs+ 
Sox2 shRNA 
Plastic 
# of Mice with 
Tumor (s.c.) 
9/16 3/8 2/16* 0/8 
Tumor Size  
(mm3) (s.c.) 
>3434 >2086 361 0 
 
    
s.c.: subcutaneous injection. *, p<0.024 (Fisher’s exact test) compared with untreated TRCs.     
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Table 2.2. Primers for reverse transcription PCR (RT-PCR). 
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Table 2.3. Primers for real time RT-PCR. 
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Table 2.4. Primers for ChIP assay. 
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CHAPTER 3. BIOMECHANICAL REGULATION OF 
CHROMATIN ORGANIZATION 
 
3.1. Introduction 
It is increasingly evident that both soluble growth factor mediated chemical 
signaling and physical microenvironment/niche mediated mechanical signaling 
play critical roles in cells, tissues, organs, and organisms in physiology and 
disease1-7. Yet we still know relatively little about how mechanotransduction is at 
work in regulating gene expression, protein synthesis, and other vital biological 
functions. One of the challenges is that it is rather difficult to separate force or 
deformation induced direct changes in proteins and genes from those that are from 
intracellular biochemical alterations, which in turn lead to additional cascades, 
although force-induced direct conformational change of, unfolding of, or 
transmission to molecules at the cell surface like integrin, talin, vinculin, and α-
actinin have been demonstrated8-12. From the findings of force-induced surface 
molecule activation and the presumed model that a local force only induces a local 
deformation, it is generally accepted that direct force impacts only occur at the cell 
surface2 and that deep cytoplasmic or nuclear mechanotransduction occur via 
intermediate biochemical activities and/or regulatory proteins in the 
cytoplasm/nucleus. One example of this is the discovery of matrix rigidity 
responsive element YAP/TAZ as a cytoplasmic mechanotransducer which 
translocate to the nucleus to regulate differentiation and proliferation13-15.  
However, a finding that the Src molecule on the endosomal membrane deep inside 
the cytoplasm can be directly (~100-300 ms) activated by a local force applied via 
integrins shows that a local force can generate a long-distance deformation impact 
in a living cell16. A follow-up work on a different enzyme Rac1 demonstrates that 
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its activation by force is rapid (<300 ms), direct (no intermediate biochemical 
activities), long-distance (can be activated on the other side of the cell from the 
point of a local force), and does not depend on prior Src activation17, fundamentally 
different from that induced by Plate-Derived-Growth Factor (PDGF). In sharp 
contrast, PDGF-induced Rac activation absolutely depends on the activation of the 
upstream molecule Src18. In addition, a recent report has provided experimental 
evidence that the coilin-SMN protein complexes in a subnuclear structure, the Cajal 
body, can be directly dissociated by force (of physiologic magnitude) applied via 
integrins at the cell surface19. These findings have advanced previous 
understandings on how external forces might alter mechanical and biological 
responses in the nucleus20-24. More recent work has shown that LaminA/C, a protein 
network that forms the nuclear lamina, is a mechanosensor, responds to tissue 
stiffness, and regulates differentiation25, translocation, and signaling of a 
mechanosensitive transcription factor26. In addition, chromatin decondensation is 
shown to depend on the degree of cell spreading/shape and cytoskeletal 
contractility27,28. Applying force directly to nesprin-1 of an isolated nucleus 
phosphorylates inner nuclear membrane protein emerin and stiffens the nucleus29, 
again suggesting that if sufficient forces could be propagated from the cell surface 
to the nuclear lamina, they might have a direct effect on nuclear structure and 
function. Together these reports suggest that it is possible to directly alter the 
condensation status of the chromatin by local forces applied via integrins, but the 
evidence that a cell surface force has a direct impact on chromatin structures 
without intermediate biochemical signaling is still lacking. Complicating the issue 
is the fact that since chromatin are very stiff structures (Young’s modulus of 
chromosomes is ~1-5 kPa)30, it is not clear at all that chromatin could be stretched 
by local surface forces of physiologic magnitudes despite deformation of other 
intranuclear structures such as Cajal bodies19 or nucleoli21 have been observed. 
Even if chromatin could be decondensed or deformed by a surface force, it remains 
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unclear if the force would alter transcription as there is evidence that a soluble 
acidic peptide decondenses chromatins and relocates genes toward the center of the 
nucleus without any impact on transcription31. 
Here we set out to test the hypothesis that a local surface force of physiologic 
magnitudes has a direct impact on the chromatin structure and the ensuring gene 
expression in a living cell. We demonstrate unequivocal evidence that chromatin 
stretching depends on the direction of the applied stresses at the cell surface, 
intranuclear proteins BAF1 and HP1 play critical roles in stabilizing chromatin and 
mediate force propagation from LINC to the chromatin, and cell-cycle related 
dihydrofolate reductase (DHFR) gene expression is associated with directional 
force application. 
3.2. Results 
A strategy to visualize chromatin stretching. We utilized a cell line that has been 
permanently transfected with BAC lac operon-DHFR transgene into DHFR-/- 
DG44 CHO (Chinese hamster ovarian) cells that stably express EGFP-dimer lac 
repressor32 (Fig. 3.1A). DHFR reduces dihydrofolate to tetrahydrofolate and is an 
essential enzyme for synthesizing thymidine. In order to allow for detection of local 
movements between chromatin regions within a single chromatin, the cell clones 
that have multiple GFP spots (~2-7) representing multi-copy BAC insertions, 
without any detectable CHO genomic DNA between BAC copies, were chosen for 
experiments32 (Fig. 3.1A, B). To apply a local shear stress via integrins, we 
employed the technique of three-dimensional magnetic twisting cytometry (3D-
MTC) that uses a magnetic bead (~4 μm in diameter), coated with saturated 
amounts of Arg-Gly-Asp (RGD) peptides33 (Fig. 3.1C, D).  In order to apply 
stresses to a spot on the cell surface in any desired direction, we first magnetized 
the magnetic bead along the Z-axis with a strong magnetic pulse (~1000 Gauss for 
<1 ms) and then turned on the weak magnetic field along the X-axis, Y-axis, or X- 
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and Y-axis simultaneously to rotate/twist the bead toward those directions (Fig. 
3.1C). We used a strategy of combining different magnitudes of the twisting fields 
along X- or/and Y-axis such that the peak magnitude of the rotational shear stress 
on the bead (and to the cell surface) was constant (Fig. 3.1E). Using this strategy, 
we were able to apply local sinusoidal shear stresses of a constant peak magnitude 
to cell surface via integrins in any desired direction. For the fixed peak stress 
magnitude of 17.5 Pa at 0.3 Hz, the bead displacement was much greater when the 
bead was sheared 90o vs 0o relative to the long axis of the cell (Fig. 3.1E, F), with 
the shear stresses at acute angles (30o, 45o, or 60o) generating in-between bead 
displacements. Since these cells exhibit extensive prestressed actin bundles along 
the long axis of the cell (Fig. 3.6), they are consistent with previously published 
results in smooth muscle cells33 that an elongated cell is mechanically anisotropic 
and appears stiffer along the long axis of the cell because of prestressed actin 
bundles (stress fibers). 
Chromatin stretching depends on stress directionality. We observed the relative 
movements of the GFP spots along the BACs during stress application (17.5 Pa at 
0.3 Hz) (Fig. 3.2A, B). Interestingly, applying stress transverse the long axis 
(Transverse Stress, or at 90o angle) results significant relative movements of the 
two GFP spots (Fig. 3.2C). In contrast, applying stresses along the long axis (Axial 
Stress, or at 0o angle) resulted in little relative movements of the two GFP spots, 
although there was some movements of same magnitudes at 0o angle (Fig. 3.2C). 
Stressing at 45o angle resulted in relative movements of in-between (90o and 0o) 
magnitudes, as expected. Since the relative movements of the GFP spots on the 
same chromatin are synchronized with the input stress with some phase lags (due 
to viscoelastic properties of the cell) and heavily depend on stressing directionality, 
these data strongly suggest that the chromatin of a living cell can be stretched by a 
local surface stress of physiologic magnitudes via the integrins. 
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Association of gene expression with chromatin stretching. To determine if 
stress-induced chromatin stretching results in specific gene expression, we 
performed fluorescence in situ hybridization (FISH) right after application of 
stresses (17.5 Pa at 0.3 Hz) for 1 hour (Fig. 3.3A).  DHFR gene expression at several 
sites near the GFP spots was observed (Fig. 3.3B). When two cells contacted each 
other, the cell with a magnetic bead moving at ~90o relative to the long axis of the 
cell exhibited much higher DHFR gene expression than the nearby cell, which 
probably experienced much lower stresses due to the fact that the stress was 
dramatically decreased across the large cell-cell contact area (Fig. 3.3C). Since 
DHFR gene expression could only be quantified in a fixed cell with FISH, a stress 
of 17.5 Pa at 0.3 Hz at a given stressing angle relative to the long axis of the cell 
was applied to the cell only once. Nevertheless, the summarized results clearly 
show the strong positive dependence of DHFR gene expression on stressing angles 
from 0o to 90o: similar gene expression levels were observed in three ranges of 
stressing angles: between 0o and 25o, 25o and 50o, 70o and 90o (Fig. 3.3D). The 
strong dependence of DHFR gene expression on stressing angles relative to the cell 
long axis, together with the observation that chromatin stretching also depends 
strongly on stressing angles,  suggests that it is the degree of local chromatin 
stretching that leads to the elevated DHFR gene expression in the living cell. 
Structural basis for force transfer to stretch chromatin Previously published 
works have shown that a matrix force is propagated to the nucleus via integrins and 
focal adhesion proteins to the cytoskeleton, the LINC (linker of nucleoskeleton and 
cytoskeleton) complex including nesprins and SUN proteins, which in turn connect 
with nuclear lamins and chromatin (reviewed in ref. 34). However, precisely how 
chromatins are physically connected to the lamins is not clear. Candidate proteins 
include Emerin, MAN1, LAP2, BAF, and HP1. To determine if any of the proteins 
play significant roles in physically constraining the chromatin, we specifically 
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silenced these proteins one by one and quantified the spontaneous movements of 
the chromatin. We hypothesized that the chromatin spontaneous movements should 
increase if the knocked-down protein is relevant. Of the six candidate molecules, 
only silencing HP1 or BANF1 with siRNA led to significant elevation of chromatin 
spontaneous movements (Fig. 3.4A, B), suggesting that both HP1 and BAF proteins 
physically tether the chromatin with the nuclear lamins and/or other nuclear 
structures. Importantly, knocking down HP1 or BANF1 resulted in downregulation 
of stress-induced chromatin stretching (Fig. 3.4C), suggesting that both HP1 and 
BAF play significant roles in mediating stress propagation from the LINC to the 
chromatin. In future, we need to confirm these findings by using different sets of 
siRNA and testing the RNAi knockdown efficiency. 
3.3. Discussion 
Our current finding that force-induced local chromatin stretching and ensuing small 
changes in local chromatin compaction and decondensation can lead to elevation in 
gene expression is in contrast to a recent report demonstrates that chromatin 
decondensation and gene relocation to the nucleus center by a soluble acidic peptide 
do not result in gene transcription31. Our results suggest that there is a major 
difference between the soluble acidic peptide induced chromatin decondensation 
and forced-induced chromatin decondensation. However, it is important to note that 
other soluble factors such as serum do induce chromatin decondensation and DHFR 
gene expression32. 
A recent report on isolated nuclei29 has shown that emerin can be phosphorylated 
by a force of ~30 pN applied directly to nesprins and the stiffness of the isolated 
nucleus is ~0.6 Pa. Since chromosomes of a living cell have a stiffness of 1-5 kPa 
30 and isolated chromosomes have a stiffness of ~0.1-1 kPa 35, about 3 orders of 
magnitude higher than the 0.6-Pa in the report, it is likely that the 30-pN force 
applied to the isolated nuclei only deformed the nuclear envelope and not the 
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underlying chromatins. Therefore it is possible that some molecules linking the 
chromatin to the lamins are lost during the isolation of the nucleus. This possibility 
is further strengthened by our discovery of the two small nuclear proteins BAF and 
HP1 that mechanically link chromatins with lamins. 
BAF is an 89-amino acid protein (~10 kD) that bridges DNA and BAF deficiency 
results in blockage of mitosis in C. elegans36. BAF condenses DNA into loops37, 
suggesting its critical role in higher order of chromatin. Our finding that BAF is 
critical for anchoring chromatin and for cell surface-force induced chromatin 
deformation reveals its importance in force propagation from nuclear lamina to 
chromatin. Our findings suggest that one has to be mindful of importance of 
maintaining the physiological conditions of a living cell when studying the 
molecular mechanisms of cellular or nuclear mechanotransduction. Heterchromatin 
Protein 1 (HP1) is a nuclear protein (MW=~22 kD) that binds methylated tails of 
histone 3 lysine 9 (H3K9) and interacts with Lamin B receptor (LBR) and thus 
contributes to the association of chromatin to nuclear lamina. HP1 is known not 
only for its roles in formation and maintenance of heterochromatin and gene 
repression38 but also for its role in euchromatic gene expression39. If HP1’s main 
function is to bring other molecules (such as histone methyltransferace SUV39h1) 
to the chromatin during decondensation, then one would predict that its 
downregulation would only elevate the spontaneous movements of the chromatin. 
However, our current observation that surface-force induced chromatin 
deformation also depends on the presence of HP1, suggesting that HP1 may also 
play a role in physically linking the Lamins to the chromatin to transmit forces to 
the chromatins. In short, our discovery of the critical mechanical roles of BAF and 
HP1 in transmitting forces to the chromatin extends their previously known roles 
and may shed light on the molecular pathways of how mechanical forces at the cell 
surface impact nuclear functions such as gene expression. 
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Currently there are several models of mechanotransduction for the nuclear 
functions. The evidence of direct unfolding of integrins and focal adhesion proteins 
and the ensuing mechanical-chemical signaling support the model of cascade 
signaling2. The discovery of cytoplasmic YAP/TAZ and their nuclear translocation 
supports the model of relay in cytoplasmic and nuclear mechanotransduction and 
differentiation13, 14. Long term application of tension to suppress protein 
degradation (e.g., structural proteins myosin II, collagen-1, and laminA) prompts 
the new force-inhibited protein degradation model39. Our discovery of a direct 
chromatin stretching and ensuring gene expression does rule out any of those 
models. Our current findings and the established physical linkage from the ECM to 
the nucleus and the role of tensed actin bundles in long-distance force propagation 
support the model of direct force impact on nuclear functions34.  However, all 
models are not mutually exclusive to each other. We suspect that these processes 
proposed in the various mechanotransduction models likely occur at different time 
scales and one particular process might dominate certain cellular function and 
behavior. It will be critical to understand how all these force initiated processes are 
integrated inside a living cell and/or a living tissue, together with signals from 
soluble factors, to generate a coherent biological response to perturbation in the 
microenvironment in order to maintain its physiological homeostasis.   
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3.4. Methods 
Cell culture. CHO DG44 cells containing dhfr BAC and stably expressing GFP-
LacI (DHFR BAC B9-2 Cell line) were cultured in Ham’s F12 media without 
thymidine and hypoxanthine (Hyclone) with 10% dialyzed FBS following 
procedures described previously32. NIH 3T3 cell line containing dhfr BAC and 
stably expressing GFP-LacI (DHFR C27-6-28)40 were maintained in Dulbecco’s 
modified Eagle medium (Mediatech Inc) containing 10% Bovine Growth Serum 
(Fisher Scientific), 1:2000 Hygromycin B (Millipore), 75 µg/ml Zeocin 
(Invitrogen).  
3D-Magnetic Twisting Cytometry. Three-Dimensional-Magnetic Twisting 
Cytometry (3D-MTC) has been described in detail previously33. In brief, three 
pairs of coils aligned in x, y, and z directions that could independently generate 
strong magnetizing fields (~1000 Gauss, <1 ms) and weak oscillatory (sinusoidal) 
twisting fields (0-75 Gauss) at frequencies up to 1000 Hz were used to magnetize 
ferromagnetic beads (4 µm in diameter) in a chosen direction and then to apply 
twisting fields in other directions. The magnetic beads that were pre-coated with 
RGD peptide or poly-L-lysin were incubated with the cells for 30 minutes to allow 
for sufficient time for formation of focal adhesions19. In order to apply a given 
peak rotational shear stress at various directions, sinusoidal oscillatory magnetic 
fields were applied with chosen peak amplitudes by applying appropriate peak 
currents to the magnetic coils in X and Y directions after application of the strong 
magnetizing field in Z direction.     
RNA FISH. Custom Sterllatis FISH Probes were designed against dhfr mRNA 
(NM_010049.3) by utilizing Stellaris RNA FISH probe Designer (Bioresearch 
Technologies Inc., Petaluma, CA). Cells were fixed in 3.7% paraformaldehyde and 
permeabilized overnight in 70% ethanol. Samples were hybridized with the dhfr 
Stellaris RNA FISH probe set labeled with Quazar 570 Dye (bioresearch 
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Technologies Inc.) following the manufacturer’s protocol and imaged in 2X SSC 
buffer immediately after hybridization. 
siRNA inhibition. Cells were transfected with siRNA using Lipofectamine 2000 
reagent (Invitrogen) following the manufacturer’s protocol. siRNA sequences are 
listed in Table 3.1. 
Antibody staining. Cells were fixed in 4% paraformaldehyde (Electron 
Microscopy Sciences) and permeabilized in  0.1% Triton X-100 in PBS (PBT), 
blocked for 1hr in blocking buffer (10% normal goat serum, 1% BSA in PBT) , 
washed 3x10 minutes in PBT, followed by primary antibody incubation (1:100) for 
45 minutes in blocking buffer, washed 3x5 minutes in PBS, followed by secondary 
antibody incubation (1:400) in 1%BSA in PBT for 30 minutes. Primary antibodies 
used in this study were Anti-YAP/TAZ D24E4 antibody (Cell Signaling, 8418), 
Anti-BANF1 antibody (Abcam, ab129184), and Anti-RNA polymerase II CTD 
repeat YSPTSPS (phospho S5) antibody (Abcam, ab5131). Secondary antibodies 
were Goat Anti-Rabbit IgG H&L (Alexa Fluor 568) (Abcam, ab175471) and Goat 
Anti-Rabbit IgG H&L (Alexa Fluor 594) (Abcam, ab15580). F-Actin was stained 
using Alexa Fluor 594 conjugated Phalloidin. (Invitrogen, A12381) 
RNA extraction and qRT-PCR. Total mRNA was isolated using RNeasy Mini 
Kit (Qiagen) following the manufacturer’s protocol. cDNA was synthesized using 
iScript Advanced cDNA Synthesis Kit (Bio-Rad Laboratories Inc.). qRT-PCR was 
performed using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) using 
CFX Connect Real-Time PCR Detection System (Bio-Rad) following the 
manufacturer’s protocol. Mouse CYBR Green primers were purchased from Bio-
Rad (Catalog Number 100-25636) for dhfr and GAPDH.   
Microscopy and live cell imaging. A Leica inverted microscope was used to image 
the cells. Live cells were imaged in imaging buffer (20 mM HEPES, 140mM NaCl, 
2.5mM KCl, 1.8mM CaCl2, 1mM MgCl2, pH 7.4). Cell membrane was 
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permeabilized using digitonin (40 µg/ml) in permeabilization buffer (20 mM 
HEPES, 110 mM Potassium Acetate, 5 mM Sodium Acetate, 1 mM EGTA, 1 µg/ml 
aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 2 mM DTT). In nuclear pore 
blocking experiments, cells were incubated for 15 minutes in 50 µg/ml Wheat germ 
agglutinin (WGA, Sigma) or Alexa-Fluor 594 conjugated WGA (Invitrogen) in 
permeabilization buffer with 40 µg/ml digitonin. ATP depletion was performed by 
incubating cells with 2 mM NaN3 and 10 mM 2-deoxyglucose in PBS for 1 hour. 
Dynamic tracking and image analysis. MATLAB software (Mathworks) was 
used for data analysis and image processing. Tracking of fluorescent spots were 
performed using a customized MATLAB code based on IDL Particle Tracking 
Software.  
Statistical analysis. Two-tailed Student’s t-test was used for all statistical analyses. 
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3.6. Figures and Tables 
 
Figure 3.1. Strategy of visualizing chromatin stretching while applying directional stresses via 
integrins. (A) Schematic representation of transgene insertions and fluorescence labeling of 
chromatin in live cells. Mouse DHFR gene were tagged with 256-mer Lac Operator (LacO) repeats 
and inserted into Bacterial Artificial Chromosome (BAC). Stable cell lines were generated by 
insertion of multiple copies of the BAC into the genome of Chinese Hamster Ovary Cells (CHO). 
GFP-Lac Repressor (GFP-LacI) was stably expressed in these cells. High affinity binding of GFP-
LacI to LacO was used to visualize transgene insertions in chromatin. (B) GFP tagged chromatin 
domains are shown inside the nucleus of a living CHO cell. Left image: nucleus is outlined by 
dashed lines; the brightfield image is overlaid with the fluorescent image. Right image: the GFP-
LacI image of the same cell. Arrows point to chromatin domains.  (C) Schematic representation of 
the 3D Magnetic Twisting Cytometry (3D MTC). A ferromagnetic bead was attached to the apical 
surface of the cells via integrins. The bead was magnetized in Z direction and twisted in arbitrary 
angles toward the X-Y plane by simultaneously modulating the amplitude of the magnetic fields in 
X and Y directions. (D) The 3D MTC setup and the microscope. (E) A live CHO cell with a 4-μm 
ferromagnetic bead (solid black circle) with GFP labeled chromatin (green). The magnetic fields 
were used to apply shear stresses toward the X-Y plane. θ represents the angle of bead rotating 
direction with respect to Y axis. (F) The magnetic bead was twisted toward the X-Y plane with θ=0º, 
30º, 45º, 60º, 90º in the same cell. In all directions, the amplitudes of the sinusoidal magnetic fields 
(at 0.3 Hz) were modulated such that the peak stress amplitude remained constant (17.5 Pa). The 
bead displacement was lower in axial direction of the cell compared to the transverse direction, 
indicating the cell is softer along the transverse direction than along its axial direction.  
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Figure 3.2. The degree of chromatin stretching depends on stressing directions. (A) A 
schematic showing the process that when a local stress was applied to the cell surface, the stress was 
propagated to the nucleus to stretch a chromatin labeled with two GFP-LacI spots. (B) A 
representative time-course image of two GFP spots (#1, #2) in the same chromatin within one 
sinusoidal loading cycle (17.5Pa at 0.3Hz).  (C) Mean Squared Displacement (MSD) of each GFP 
spot when stress was applied in transverse 90º angle (transverse direction) (left panel), 45º (middle 
panel), and 0º (axial direction) (right panel). It is apparent that chromatin stretching was highest 
when the stress was applied along the transverse direction relative to the long axis of the cell.  
 80 
 
Figure 3.3. Gene expression is tightly associated with the degree of chromatin stretching. (A) 
A schematic to represent the process of Fluorescence in situ Hybridization (FISH) to quantify force-
induced gene expression at the location of transgene insertions with Cy3-conjugated oligo-probes 
to detect the expression of DHFR mRNA. (B) From the left, a brightfield image of a live CHO cell 
(its nucleus was highlighted with dashed lines) with a magnetic bead (black dot; the arrow represents 
the direction of the bead center displacement); middle left, GFP-LacI spots (green) were shown 
indicating the location of the transgene insertions; middle right, DHFR mRNA expression was 
quantified using Cy3-conjugated FISH probes (red); right, overlay of Cy3-FISH (red) with GFP-
(17.5Pa at 0.3Hz) was applied via a RGD-coated magnetic bead (the black dot within the dashed 
line) for 1 hour and FISH intensity was measured. Color bar shows the fluorescence intensity 
(arbitrary units).  The cell on the left had a magnetic bead and the one on the right had no bead. As 
indicated by the widths of the white arrows, the fluorescence intensity (and thus DHFR expression) 
at transgene insertions was much higher for the cell on the left than that for the cell on the right. 
Yellow arrow represents the direction of bead center displacement. (D) Summarized data of DHFR 
expression at transgene insertions as a function of the angles between the cell long axis and the 
direction of stress application (Stress Angle). FISH intensity was normalized to the average intensity 
of FISH in the cells without stress. Force induced gene expression is highest in the transverse 
direction, corresponding to the direction at which the chromatin stretching was largest. Each cell 
was stressed only at one particular angle. Mean±s.e.m. Data is represented as the moving average 
(n=30) of 150 cells.   
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Figure 3.4. Structural basis of force transfer to stretch chromatin. (A) Representative images 
of trajectories of spontaneous movements of GFP-LacI labeled transgenes in live CHO cells siRNA 
was used to knock down mRNAs of the five proteins that are known to interact with chromatin and 
nuclear lamina. Control=a wild-type intact CHO cell. Frame rate=300 ms. Scale bar, 100 nm. (B) 
HP1 and Baf anchor chromatins. Summarized data of quantification of the Mean (frame-to-frame) 
Displacement of spontaneous movements. Neg Ctrl=treated with scrambled siRNA. Since Mean 
Displacement was significantly increased after silencing HP1 and Banf1, suggesting that the 
proteins of these two genes are required for anchoring the chromatin to stable nuclear structures-
Lamins. Mean±s.e.m.; n=30 cells; ***, p<0.001. (C) HP1 and Baf transmit stresses from Lamins to 
chromatins. HP1 and Banf1 genes were silenced using siRNA and local oscillatory forces are 
applied to the cell surface using MTC (17.5 Pa at 0.3 Hz). Force-induced displacement of GFP-LacI 
labeled chromatin transgenes was measured. It appears that HP1 and Baf proteins are necessary for 
propagation of stresses from the cell surface to the chromatin. Mean±s.e.m.; n=3 cells per condition; 
***, p<0.001. (D, E) Acto-myosin contractility regulates chromatin condensation. (D) 
Representative images of CHO cells that were without (left) and with (right) treatment by myosin 
light chain kinase inhibitor ML7 (25µM for 30 min). (E) Summarized data for contour length (length 
of the line connecting GFP spots) and the number of GFP spots (number of active transgenes) 
without (Control) and with ML7 treatment. ML7 treated cells had lower contour lengths and hence 
fewer GFP spots, indicating that the chromatin is more condensed. Mean±s.e.m.; n=10 cells, >3 
separate experiments. *, p<0.05. (F) Inhibition of actomyosin contractility downregulates DHFR 
gene expression. Cy3 FISH intensity was used to measure DHFR mRNA expression at transgene 
insertions. Intensity values of ML7 treated cells were normalized by the FISH intensity in control 
cells (Control). Mean±s.e.m.; n=55 cells, >3 independent experiments. **, p<0.01.  
 82 
 
Figure 3.5. A model for direct force impact on gene activation. A local surface force via integrins 
is propagated though the myosin tensed actin cytoskeleton to the LINC complex, to nuclear lamins, 
and then is transferred to the chromatin through BAF and HP1 proteins. The stretched chromatin 
facilitates binding of the RNA Polymerase II, to unregulate DHFR gene expression. 
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Figure 3.6. CHO cells are elongated and exhibit stress fibers along the long axis of the cells. 
CHO cells were fixed and stained with Alexa Fluor 594-Palloidin.   
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Figure 3.7. The CHO chromatin stretching exhibits phase lags from the input stress. (A) A 
sinusoidal local stress (24.5Pa at 0.3Hz) was applied to cell surface via a RGD-coated magnetic 
bead using MTC and the chromatin stretching was monitored by tracking force-induced cyclic 
movements of the GFP-LacI transgene insertions. (B) Chromatin was stretched with ~0.32 seconds 
lag (~36o) with respect to the applied stress applied, indicating that that the cell was viscoelastic.  
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Figure 3.8. Stiff substrates decondense chromatin.  (A) Representative images of CHO cells 
cultured on polyacrylamide gels with 0.6, 2, or 8 kPa stiffness (from left to right), coated with 
collagen-1. Nucleus was indicated with dashed lines and GFP-LacI spots with a white arrow. (B) 
Average distance of the DHFR transgenes from the nuclear periphery. Mean±s.e.m.; n=10 cells; *, 
p<0.05. (C) Number of GFP-LacI spots. Mean±s.e.m., n=10 cells; ***, p<0.001. (D) Contour length.  
Mean±s.e.m.; n=10 cells; ***, p<0.001; **, p<0.01. (E) qRT_PCR data representing dhfr expression 
15 hours after plating on PA gels, normalized vs 0.6 kPa expression level. GAPDH used as 
reference. Mean±s.e.m.; n=3 ; *, p<0.05  
 86 
 
Figure 3.9. Spontaneous vibrations in chromatin are driven by ATP.  Histogram of the 
spontaneous vibration of GFP-LacI spots are shown in (A) control cells and (B) ATP depleted cells.  
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Figure 3.10. Myosin family of motor proteins contribute to the spontaneous vibration of 
chromatin.  Average displacement per frame of spontaneous movement of chromatin GFP spots. 
Cells were incubated with ML7 (25 μM, 30 min), Blebbistatin (50 μM, 30 min), MyoVin1 (5 μM, 
2.5 hrs), Triiodophenol (5 μM, 3.5 hrs).Mean±s.e.m; n=30 spots; *, p<0.001; **, p<0.01, ***, 
p<0.05.  
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Figure 3.11. Nanoneedle stretching of chromatin structures. A nanoneedle was inserted into the 
nucleus of living cells and the chromatin was stretched. (A) Representative Image of the process 
.(B) Before and (C) after stretching chromatin.  
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Table 3.1. Sequence of siRNA. 
 
Gene Vendor Catalog# Sequence (5’3’) 
HP1a Life Technologies 160043 CCCUCUAACCCUGCCAAUUtt 
Lamin a Life Technologies 93698 GGAGCUAGAAAAGACAUACtt 
Lamin b1 Life Technologies 156140 GGACUUGGAGUUUCGUAAtt 
Lamin b2 Life Technologies 156145 CCUUUUCUUUUACGCCUAUtt 
Banf1 Life Technologies 70329 GGAAAAGAUGGCUGUUGUCtt 
Man1 Life Technologies 503939 GCUGUACAGUCAUAGAUGAtt 
HP1b Life Technologies 60494 GGGCAAGGUGGAAUAUCUUtt 
LAP2 Life Technologies 187347 GCAGGGAACUGAAUCGAGAtt 
Emerin Life Technologies 61399 GGAGAGUUAUUUGACCACCtt 
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CHAPTER 4. CONCLUSIONS AND FUTURE 
DIRECTIONS 
 
The main focus of this dissertation is to study the effect of mechanical forces on 
nuclear events in single living cells. Specifically, we studied the mechanisms that 
mechanical forces can regulate epigenetics in cancer or modulate chromatin 
organization and gene expression in single living cells. 
In chapter 3, we showed that matrix softness regulates the plasticity of tumor 
repopulating cells (TRC). We identified a mechanism by which forces applied to 
the cell surface can regulate methylation level of histone H3K9. We showed soft 
fibrin matrix down-regulates the level of H3K9 methylation at Sox2 promoter 
which in turn upregulates Sox2 expression. We showed β1 integrins are necessary 
for force-induced methylation of H3K9, which depends on G9a and SUV39h1 
methyltransferases. Matrix softness also promotes the downregulation of Cdc42, a 
small GTPase protein that regulates cellular stiffening response. Cdc42 knockdown 
in melanoma cells inhibits stiffening response while overexpression of Cdc42 in 
TRCs can rescue the stiffening response. TRCs show plasticity when cultured on 
plastic substrate when plated on rigid plastic dish. i.e. Sox2 expression decreases, 
H3K9 methylation level increases, and cells become stiffer. In this chapter, we 
discussed the biomechanical and biochemical mechanisms that regulate 
tumorigenic properties of the cells and we showed how the mechanics of tumor 
microenvironment can regulate the tumorigenicity of cancer cells.  
In chapter 4, we further investigated the effect of mechanical forces on chromatin 
structure and gene expression. The fact that mechanical forces can induce gene 
expression is not novel. However, the current understanding of the field mostly 
relies on biochemical pathways by which mechanical signals can be translocated to 
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the nucleus from the cytosol. Here, we showed mechanical forces applied to cell 
surface can indeed stretch the chromatin and induce gene expression without the 
need for intermediate cytosolic biochemical pathways. We showed force induced 
chromatin unfolding is anisotropic and depends on loading direction. In fact, gene 
expression response also follows the same anisotropic response. It has been 
previously shown that mechanical forces propagate through integrins, focal 
adhesion complex, cytoskeleton, the LINC complex and to the nuclear lamina. We 
identified BAF and HP1 as the key linking proteins that are responsible for 
transmission of force from the nuclear lamina to the chromatin. We further studied 
the spontaneous vibration of chromatin. We showed that these vibrations are driven 
by ATP and that myosin family of motor proteins are mainly responsible for driving 
these random vibrations.  
In conclusion, we showed biomechanical cues are equally important as biochemical 
cues. They can regulate epigenetics, chromatin organization, and gene expression 
deep inside the nucleus. 
There are, however, many important questions remain to be studied in future. We 
need to explore the dependence of chromatin unfolding on load frequency, 
amplitude, and integrin subtypes. We should further investigate the force-induced 
chromatin unfolding and gene expression on protein translocation, Calcium 
signaling, and other soluble factors. Stress propagation pathway from the cell 
surface to the nucleus is certainly an interesting topic to study. On the other hand, 
we need to do further study how force induced epigenetic modification can be 
linked to force induced changes in chromatin organization. 
These findings will open a new direction in the field of mechanobiology to study 
force-induced chromatin unfolding and epigenetic modification in human 
development, physiology, disease, cancer, and aging. 
